Molecular Diagnostic Assay Systems
The molecular diagnostic assay system addresses the need for rapid and accurate diagnostics in resource-limited areas by employing a portable device with automated assays and cloud-based connectivity, ensuring timely treatment and outbreak monitoring.
Patent Information
- Application Number
- JP2022069108
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2015-07-24
- Filing Date
- 2022-04-19
- Publication Date
- 2024-11-26
- Estimated Expiration
- 2036-07-22
AI Technical Summary
There is a need for reliable, portable, and rapid diagnostic tools capable of performing complex molecular tests in resource-limited conditions to facilitate early detection and response to infectious disease outbreaks, particularly in remote and undeveloped areas where healthcare facilities are scarce.
A molecular diagnostic assay system that includes a portable testing device with a secure cloud-based connection, allowing for real-time data sharing and rapid, accurate diagnostic results, utilizing improvements such as brushless DC motors, ultrasonic horns, and thermo-optic subassemblies for automated assays and data transmission.
Enables rapid, accurate diagnostic results within 1-2 hours, facilitating early treatment and outbreak monitoring, even in resource-limited settings, by providing a fully portable and easy-to-use system with cloud-based connectivity.
Smart Images

Figure 0007589875000011 
Figure 0007589875000012 
Figure 0007589875000013
Abstract
Description
[Technical field]
[0001] CROSS-REFERENCE TO RELATED APPLICATIONS
[0002] This application claims the benefit of priority to U.S. Provisional Patent Application No. 62 / 196,845, entitled "Molecular Diagnostic Assay System," filed July 24, 2015, the entire contents of which are incorporated herein by reference.
[0003] This application relates generally to U.S. patent application Ser. No. 13 / 843,739, filed Mar. 15, 2013, entitled "Honeycomb tube," and U.S. patent application Ser. No. 13 / 843,739, filed Mar. 14, 2013, entitled "Remote Monitoring of Medical Devices," and U.S. patent application Ser. No. 13 / 843,739, filed Mar. 15, 2013, entitled "Thermal Control Device and Methods of Use," both of which are concurrently filed herewith, and U.S. patent application Ser. No. 13 / 843,739, filed Mar. 14, 2013, entitled "Remote Monitoring of Medical Devices," both of which are concurrently filed herewith, and U.S. patent application Ser. No. 13 / 843,739, filed Mar. 15, 2013, and U.S. patent application Ser. No. 13 / 843,739, filed Mar. 14, 2013, entitled "Honeycomb tube," both of which are concurrently filed herewith, and U.S. patent application Ser. No. 13 / 828,741, entitled "Fluid Processing and Control Devices," U.S. Patent No. 8,048,386, filed February 25, 2002, entitled "Fluid Processing and Control," and U.S. Patent No. 6,374,684, filed August 25, 2000, entitled "Fluid Control and Processing System," all of which are incorporated herein by reference in their entireties for all purposes. [Background technology]
[0004] Advances in technology have made today's world an increasingly connected environment. While air travel allows an average person to travel across the globe from one continent to another within the same day, infectious pathogens can spread rapidly, exposing the entire global population to deadly diseases that can have devastating consequences. Recent outbreaks of Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS), and Ebola are examples of how a public health event originating in one region of one continent can quickly escalate into a major global concern. Today's highly mobile world demands reliable diagnostic tools that provide results in real time and aid in early detection and emergency response to any potential epidemics.
[0005] On the other hand, there are many remote and underdeveloped areas in the world where health care for the local population is not easily accessible. Lack of proper access to health care facilities such as hospitals and clinics, or even health product / service distributors (e.g., pharmacies), severely impedes efforts to timely diagnose and treat patients, especially those suffering from infectious diseases, making it difficult to properly assess the risk of epidemics and effectively contain the rapid spread of epidemics. Thus, there is a dire need for new and improved diagnostic tools that are highly mobile and capable of performing multiplex molecular tests that provide rapid, reliable, and accurate diagnostic results regardless of location, be it a health care facility, local clinic, retail service provider, or in resource-limited conditions where power, communication (e.g., Internet), traditional health care services, and / or health care professionals are not routinely available. Summary of the Invention [Problem to be solved by the invention]
[0006] The present inventors have developed a highly sophisticated, yet completely portable and surprisingly easy to use molecular diagnostic assay system that meets the above needs. By improving upon existing molecular diagnostic assay systems (e.g., Cepheid's GeneXpert® system), the new molecular diagnostic assay system described herein includes a medical diagnostic device that is optionally battery powered and is generally small, lightweight, and completely portable for use anywhere a patient may be, even away from a hospital, laboratory, or pharmacy. The diagnostic device is capable of running fully automated diagnostic assays (optionally for simultaneous detection of multiple pathogens) to obtain accurate results quickly (usually within 1-2 hours, and as fast as 15-20 minutes). It is easy to operate, and using one or more prefabricated assay cartridges, it is possible to rapidly obtain test results that indicate whether a patient is carrying a particular pathogen or has a particular medical condition.
[0007] This newly designed molecular diagnostic assay system also includes a component that provides a secure cloud-based connection to transmit test results from the handheld testing device to a remote reporting system, a centralized data collection or processing center, or to a mobile device, such as a handheld device, that the physician or patient uses to receive the diagnostic report. Such cloud-based connectivity allows for virtually instantaneous data sharing, allowing physicians to initiate patient treatment without delay, as well as enabling large-scale monitoring and reporting of any potential outbreaks.
[0008] These key features circumvent current limitations that tend to impede and hinder early diagnosis and effective treatment of patients in poor and remote areas where healthcare facilities are scarce and diagnostic testing capacity is lacking. This newly designed molecular diagnostic assay system is the first true point-of-care diagnostic tool with the advantage of rapid deployment and fully operational in virtually any environment, truly enabling diagnostic testing for people wherever they are. The combination of its deployability, its rapid and accurate diagnostic capabilities, its technical sophistication and ease of operation, and its cloud-based connectivity make this new molecular diagnostic assay system the ultimate solution for emerging markets and an innovative trendsetter that will define the future of medical diagnostic testing. [Means for solving the problem]
[0009] In one aspect, the present invention provides an improved diagnostic assay system that can include improvements in various subassemblies, including door actuation assemblies, syringe and valve actuators, sonication horns, thermal and optical detection assemblies, and instrument management / communication systems. It will be understood that any of these subassemblies, individually or in combination with any other subassembly, can be included in such a diagnostic assay system to provide the improved performance described herein.
[0010] In some embodiments, the present invention includes diagnostic assay systems adapted to receive an assay cartridge (sometimes referred to as a "sample cartridge" or a "test cartridge"). Such systems can include any one or any combination of the various features and subassemblies described herein.
[0011] In some embodiments, the diagnostic assay system includes a brushless DC (BLDC) motor operatively coupled to, for example, the door opening mechanism and any of the cartridge loading system, syringe actuators, and / or valve actuators.
[0012] In some embodiments, the diagnostic assay system includes a door opening mechanism that is coupled to the cartridge loading mechanism and driven by a reversible variable speed mechanism.
[0013] In some embodiments, the diagnostic assay system includes a syringe drive operatively coupled to an n-phase BLDC motor and controlled based at least in part on the monitored current draw of the BLDC motor.
[0014] In some embodiments, the diagnostic assay system includes a valve drive mechanism operatively coupled to an n-phase BLDC motor that is based at least in part on voltage signals provided by n voltage sensors in the BLDC motor without the use of encoder hardware or position sensors.
[0015] In some embodiments, the diagnostic assay system includes a sonication horn engageable with the assay cartridge to lyse biological material within the assay cartridge and operatively coupled to a controller configured to control sonication based at least in part on the frequency that provides the highest output amplitude as the resonant frequency.
[0016] In some embodiments, the diagnostic assay system includes a thermal control device having a first thermoelectric cooler thermally engageable with a reaction vessel (sometimes referred to as a "reaction tube") of the assay cartridge, and at least one other thermal manipulation device thermally coupled to the first thermoelectric cooler and for increasing the efficiency of the first thermoelectric cooler to facilitate rapid thermal cycling of the reaction vessel between first and second temperatures in the first thermoelectric cooler.
[0017] In some embodiments, the diagnostic assay system includes an optical excitation / detection block that is mountable to the reaction vessel to emit excitation energy into the fluid sample in the reaction vessel at an angle that is substantially orthogonal to the angle at which excitation is detected from one or more ends (minor faces) and / or major faces of the reaction vessel.
[0018] In some embodiments, the diagnostic assay system includes a communications unit configured to wirelessly communicate with a user's mobile device to receive user inputs related to system functions involving assay cartridges contained within the system, and to relay diagnostic results related to the assay cartridges to the mobile device.
[0019] Some embodiments of the present invention relate to a door operation system for a diagnostic assay system. The system can include a chassis of the diagnostic assay system. A brushless DC (BLDC) motor can be coupled to the chassis of the diagnostic assay system. A back-drivable transmission can be operated by the BLDC motor. A door can be moved from a closed position to an open position (and from the open position to the closed position) relative to the chassis of the diagnostic assay system. The BLDC motor can be configured to operate the back-drivable transmission based on a current measurement of the BLDC motor, the current measurement relating to a back-drivable event for the back-drivable transmission.
[0020] Some embodiments of the present invention relate to a method of operating a door opening / closing system for a diagnostic assay system, in which a command to open a cartridge receiving door of the diagnostic assay system can be received. A brushless DC (BLDC) motor coupled to a back-drivable transmission operatively coupled to the door and to a cartridge loading mechanism can be operated to open the door from a closed position (and vice versa). A first back-drive event to the back-drivable transmission can be detected by monitoring the current. Upon detection of the first back-drive event, operation of the BLDC motor to position the door in an open position can be stopped and the cartridge loading mechanism can be oriented to receive an assay cartridge.
[0021] Some embodiments of the present invention relate to a syringe actuation system for a diagnostic assay system. The system may include a diagnostic assay system chassis. A brushless DC (BLDC) motor may be coupled to the diagnostic assay system chassis. A back-drivable lead screw may be operable by the BLDC motor. A plunger rod may be operable by the lead screw to engage a plunger tip with a syringe passage of an assay cartridge. The BLDC motor may be configured to operate the lead screw by monitoring a current draw of the BLDC motor, the current being related to pressure changes within the removable assay cartridge.
[0022] Some embodiments of the present invention relate to a method of operating a syringe for a diagnostic assay system. A command can be received to power a brushless BLDC motor. The brushless BLDC motor can be operable to rotate a back-drivable lead screw. A plunger rod is coupled to the lead screw and movable thereby. Power can be provided to the BLDC motor to move the plunger rod to engage a plunger tip within a syringe passage of an assay cartridge. At least one current associated with the operation of the BLDC motor can be monitored to determine a property of the removable assay cartridge. A change in the current of the BLDC motor can be detected. Based on the detection of the change in current, the operation of the BLDC motor can be altered within the removable assay cartridge.
[0023] Some embodiments of the present invention relate to a horn assembly having an ultrasonic horn and a horn housing. The horn assembly engages a disposable assay cartridge via a movable mechanism. The movable mechanism moves the ultrasonic horn between a disengaged or retracted position for loading and unloading the assay cartridge from the diagnostic instrument module and an engaged or advanced position for forcing the horn into engagement with the sonication chamber of the assay cartridge for lysis of biological cells in the chamber as part of a diagnostic assay, including but not limited to polymerase chain reaction analysis. In some embodiments, the movable mechanism includes a spring or biasing mechanism and a cam that engages a wedge surface of the horn housing to effect movement of the horn between the lowered and raised positions. In some embodiments, movement of the horn assembly is effected by an actuator common to other movable components such as the load / eject arm and the cartridge module door to provide efficient coordinated movement of multiple components within the diagnostic instrument module.
[0024] Some embodiments of the present invention relate to a horn having an ultrasonic horn and at least one piezoelectric actuator controlled under closed loop feedback. In some embodiments, the horn includes a control circuit that utilizes sinusoidal control and phase matching for resonant frequency control. These features ensure in-phase vibration between the piezoelectric actuators, allowing the use of an ultrasonic horn with smaller size and power specifications than would otherwise be possible, providing stable and robust delivery of ultrasonic energy.
[0025] Some embodiments of the present invention relate to a method of operating a valve driver, comprising: providing power to a brushless DC (BLDC) motor coupled to a chassis and receiving a command to move the valve driver to a particular position; the valve driver can be configured to rotate a position of a valve body of a removable assay cartridge; and a gearbox can be coupled between the BLDC motor and the valve driver; the BLDC motor does not include position sensor or encoder hardware, and may include a number of Hall effect sensors; the BLDC motor is provided with power to rotate a shaft of the BLDC motor a particular number of turns to move the valve driver to a particular position based on a sinusoidal signal generated by the Hall effect sensor.
[0026] Some embodiments of the present invention relate to a valve driver operation system. The system may include a valve driver chassis. A brushless DC (BLDC) motor may be coupled to the chassis. The BLDC motor does not include position sensor or encoder hardware and may include a number of Hall effect sensors. A gearbox may be coupled to the BLDC motor. A valve driver may be coupled to the gearbox. The valve driver may be configured to rotate a position of a valve body of a removable assay cartridge. A position of the valve driver output may be determined based on analysis of a sinusoidal signal generated by the Hall effect sensor.
[0027] Some embodiments of the present invention relate to diagnostic devices that can include a thermal optical subassembly ("TOS") that includes a thermal control device component and an optical excitation / detection component. In some embodiments, the thermal control device includes a thermoelectric cooler ("TEC") component that performs thermal cycling of the reaction vessel. The optical excitation / detection component performs excitation and optical detection of the target analyte with improved control, speed, and efficiency. In some embodiments, the TOS includes a mounting component that interfaces with the thermal control device and the optical component and defines a cavity that receives the reaction vessel having a fluid sample prepared for assaying the target analyte. In some embodiments, the mounting component provides the thermal control device and the optical component in close proximity to the reaction vessel to allow simultaneous or sequential thermal cycling, excitation, and detection for amplification of the target analyte. In some embodiments, the reaction vessel includes a microarray or multiple individual reaction wells and / or a pre-amplification chamber within the reaction vessel. In some embodiments, the TOS includes one or more mechanisms for moving the thermal control device to compressively engage at least one surface of the reaction vessel when the reaction vessel is placed within the diagnostic device to enhance thermal cycling efficiency. In some embodiments, the TOS is integrated with one or more printed circuit boards (PCBs), processors, and controllers to coordinate thermal cycling and optical excitation / detection according to a particular assay. In some embodiments, the TOS includes sensors that detect the proximity of a reaction vessel or an associated sample assay cartridge, facilitating positioning and operation of thermal control devices and / or optical components relative to the reaction vessel.
[0028] Some embodiments of the present invention relate to a thermal control device comprising a first TEC having an active surface and a reference surface, a second TEC having an active surface and a reference surface, and a thermal capacitor or thermal interposer disposed between the first and second TEC devices such that the reference surface of the first TEC is thermally coupled to the active surface of the second TEC via the thermal capacitor. In some embodiments, the thermal interposer is disposed between the first and second TEC devices. In some embodiments, the thermal interposer acts as a thermal capacitor. In some embodiments, the thermal control device includes a controller operatively coupled to each of the first and second TEC devices. The controller is adapted to operate the second TEC simultaneously with the first TEC to increase the speed and efficiency of operation of the first TEC as the temperature of the active surface of the first TEC changes from an initial temperature to a desired target temperature.
[0029] Some embodiments of the invention relate to optical components that may include an optical excitation block and an optical detection block disposed on an optical mount configured to receive a reaction vessel. In some embodiments, the reaction vessel comprises two opposing major planar walls spaced apart by a minor planar wall, at least two of the minor planar walls being offset from each other by about 90 degrees. In some embodiments, the optical excitation block is disposed to deliver excitation energy into the reaction vessel through one minor wall, and the optical detection block is disposed to detect along a major planar surface of the reaction vessel. In some embodiments, excitation and detection are through opposing minor walls of the reaction vessel. In some embodiments, the optical excitation and detection components are orthogonal to each other. The optical components are configured to have a relatively small numerical aperture (e.g., low angular divergence) compared to conventional systems. In such a configuration, a smaller numerical aperture provides a larger detection volume, thereby improving optical sensitivity and facilitating optical alignment.
[0030] In another aspect, the TOS includes a sensor that detects the proximity and / or position and individual characteristics of an assay cartridge or reaction vessel associated with the TOS. In some embodiments, the sensor is a near-field wireless communication sensor that detects when an assay cartridge is loaded into a diagnostic device (often referred to as a "diagnostic module") of a diagnostic assay system, identifies the assay, and links the cartridge to a sample identifier. In some embodiments, the TOS includes a controller for coordinating operation of the thermal control device and the optical module in response to the sensor.
[0031] Some embodiments of the present invention relate to a method of managing a diagnostic assay system with a mobile device. User input can be received at the mobile device to control the functionality of the diagnostic assay device. In response to receiving the user input, control information can be sent to the diagnostic assay device using the mobile device. Data (e.g., medical data) from the diagnostic assay device can be received at the mobile device. The data can be relayed to a server without storing or recording the data.
[0032] Some embodiments of the present invention relate to a diagnostic assay device having a communications subsystem. The system may include a diagnostic component. A processor may be communicatively coupled to the communications subsystem and the diagnostic component. The processor may be configured to utilize the communications subsystem to cause the diagnostic assay device to wirelessly receive device commands from a mobile device. The processor may also be configured to wirelessly transmit device command responses to the mobile device using the communications subsystem. The processor may also be configured to perform a test using the diagnostic component. The processor may also be configured to utilize the communications subsystem to wirelessly transmit encrypted diagnostic information (e.g., medical information) indicative of a test result to a remote server. [Brief description of the drawings]
[0033] [Figure 1A]FIG. 1 is a perspective view of a diagnostic assay system according to some embodiments of the present invention. [Figure 1B] FIG. 1 is an exploded view of a diagnostic assay system according to some embodiments of the present invention. [Figure 2A] FIG. 1 is a perspective view of a brushless DC (BLDC) motor according to some embodiments of the present invention. [Figure 2B] FIG. 1 is a perspective view of a brushless DC (BLDC) motor according to some embodiments of the present invention. [Figure 2C] FIG. 1 is a perspective view of a brushless DC (BLDC) motor according to some embodiments of the present invention. [Figure 2D] 1 is a sinusoidal variable voltage output waveform graph of a BLDC motor with additional notation illustrating a process for encoding the angular mechanical position of the motor's rotor in accordance with some embodiments of the present invention. [Figure 2E] FIG. 1 is a circuit diagram for controlling a BLDC motor according to some embodiments of the present invention. [Figure 3A] FIG. 1 is a diagram of a model for determining torque output of a BLDC motor according to some embodiments of the present invention. [Figure 3B] FIG. 1 is a diagram of a model for determining torque output of a BLDC motor according to some embodiments of the present invention. [Figure 3C] FIG. 1 is a diagram of a model for determining torque output of a BLDC motor according to some embodiments of the present invention. [Figure 4A] 1 is a perspective view of a door opening mechanism according to some embodiments of the present invention. [Figure 4B] FIG. 1 is a cross-sectional view of a diagnostic assay system in use according to some embodiments of the present invention. [Figure 4C] FIG. 1 is a cross-sectional view of a diagnostic assay system in use according to some embodiments of the present invention. [Figure 4D] FIG. 1 is a cross-sectional view of a diagnostic assay system in use according to some embodiments of the present invention. [Figure 4E] FIG. 1 is a cross-sectional view of a diagnostic assay system in use according to some embodiments of the present invention. [Figure 5A] FIG. 1 is a cross-sectional view of a diagnostic assay system in use according to some embodiments of the present invention. [Figure 5B] FIG. 1 is a flow diagram of a method for operational aspects of a diagnostic assay system according to some embodiments of the present invention. [Figure 5C] FIG. 1 is a flow diagram of a method for operational aspects of a diagnostic assay system according to some embodiments of the present invention. [Figure 6A] FIG. 1 is a perspective view of a valve actuation mechanism according to some embodiments of the present invention. [Figure 6B] FIG. 1 is a perspective view of a valve actuation mechanism according to some embodiments of the present invention. [Figure 6C] 11 is a graph of output signal versus valve actuation position according to some embodiments of the present invention. [Figure 7A] FIG. 1 illustrates an ultrasound horn assembly for use in a diagnostic assay system according to some embodiments of the present invention. [Figure 7B] FIG. 1 illustrates an ultrasound horn assembly for use in a diagnostic assay system according to some embodiments of the present invention. [Figure 8A] FIG. 2 is a component diagram of an ultrasonic horn assembly according to some embodiments of the present invention. [Figure 8B] FIG. 2 is a component diagram of an ultrasonic horn assembly according to some embodiments of the present invention. [Figure 8C] FIG. 2 is a component diagram of an ultrasonic horn assembly according to some embodiments of the present invention. [Figure 8D] FIG. 2 is a component diagram of an ultrasonic horn assembly according to some embodiments of the present invention. [Figure 9A] 1A-1D are cross-sectional views of a diagnostic assay system during and after loading of an assay cartridge according to some embodiments of the present invention. [Figure 9B] 1A-1D are cross-sectional views of a diagnostic assay system during and after loading of an assay cartridge according to some embodiments of the present invention. [Figure 10A]1A-1D are cross-sectional views of an assay cartridge according to some embodiments of the present invention. [Figure 10B] FIG. 1 is a cutaway cross-sectional view of an assay cartridge loaded into a diagnostic assay system with an ultrasonic horn assembly, according to some embodiments of the present invention. [Figure 11A-1] 1 is a side view of a horn assembly in an engaged position according to some embodiments of the present invention. [Figure 11A-2] 1 is a cross-sectional view of a horn assembly in a disengaged position according to some embodiments of the present invention. [Figure 11B-1] 1 is a side view of a horn assembly in an engaged position according to some embodiments of the present invention. [Figure 11B-2] 1 is a cross-sectional view of a horn assembly in an engaged position according to some embodiments of the present invention. [Figure 12A] FIG. 1 illustrates an exemplary ultrasonic horn assembly, according to some embodiments of the present invention. [Figure 12B] 1 is a control diagram of an exemplary ultrasonic horn operation, according to some embodiments of the present invention. [Figure 13] FIG. 11 is a diagram of a transfer function for horn assembly control according to some embodiments of the present invention. [Figure 14] FIG. 2 is a control scheme diagram for a horn assembly, according to some embodiments of the present invention. [Figure 15] FIG. 2 is a control diagram of a horn assembly according to some embodiments of the present invention. [Figure 16] FIG. 2 is a control diagram of a horn assembly according to some embodiments of the present invention. [Figure 17] FIG. 2 is a control diagram of a horn assembly according to some embodiments of the present invention. [Figure 18] FIG. 2 illustrates an exemplary TOS subassembly prior to insertion into an assay module, according to some embodiments of the present invention. [Figure 19A] FIG. 2 is a front view of an exemplary TOS subassembly according to some embodiments of the present invention. [Figure 19B]FIG. 2 is a rear view of an exemplary TOS subassembly according to some embodiments of the present invention. [Figure 20A] FIG. 2 is an exploded view of an exemplary TOS according to some embodiments of the present invention. [Figure 20B] FIG. 2 is an exploded view of an exemplary TOS according to some embodiments of the present invention. [Figure 21A] FIG. 2 is a diagram of optical components and associated PCB of an example TOS according to some embodiments of the present invention. [Figure 21B] FIG. 2 is a diagram of optical components and associated PCB of an example TOS according to some embodiments of the present invention. [Figure 22A] FIG. 1 illustrates an example thermal control device component and associated PCB with rigid-flex connections in an example TOS according to some embodiments of the present invention. [Figure 22B] FIG. 1 illustrates an example thermal control device component and associated PCB with rigid-flex connections in an example TOS according to some embodiments of the present invention. [Figure 23A] FIG. 1 illustrates an example thermal control device component configured to interface with an optical mount of an example TOS in accordance with some embodiments of the present invention. [Figure 23B] FIG. 1 illustrates an example thermal control device component configured to interface with an optical mount of an example TOS in accordance with some embodiments of the present invention. [Figure 24A] 1A-1C are diagrams of an exemplary thermal control device component movably coupled to an optical mount in an open state, according to some embodiments of the present invention. [Figure 24B] 1A-1C are diagrams of clamped views of an exemplary thermal control device component movably coupled to an optical mount, according to some embodiments of the present invention. [Diagram 25] 1A-1C are diagrams of example thermal control device components and a slide base movably coupled to an optical mount, according to some embodiments of the present invention. [Figure 26A]1 illustrates an exemplary thermal control device component movably coupled to a sliding base actuated by a modular door rack, according to some embodiments of the present invention. [Figure 26B] 1 illustrates an exemplary thermal control device component movably coupled to a sliding base actuated by a modular door rack, according to some embodiments of the present invention. [Figure 27] FIG. 2 is an exemplary block control diagram of a TOS component according to some embodiments of the present invention. [Figure 28] 1 is an illustrative schematic diagram of optical and thermal control components of a TOS, according to some embodiments of the present invention. [Figure 29] FIG. 1 is a diagram of an exemplary TOS for use in a diagnostic assay system, according to some embodiments of the present invention. [Figure 30A] 1A-1C show two exemplary optical component configurations for use with reaction vessels of a diagnostic device, according to some embodiments of the present invention. [Figure 30B] 1A-1C show two exemplary optical component configurations for use with reaction vessels of a diagnostic device, according to some embodiments of the present invention. [Figure 30C] 2 is a detailed schematic diagram of an exemplary optical component configuration according to some embodiments of the present invention. [Diagram 31] FIG. 3 illustrates exemplary details of excitation block 310 and detection block 320 according to some embodiments of the present invention. [Diagram 32] FIG. 2 illustrates fluorescence detection with excitation and detection components of an exemplary optical component, according to some embodiments of the present invention. [Figure 33A] 1 is a schematic diagram of a thermal control device according to some embodiments of the present invention. [Figure 33B] FIG. 2 is a model diagram of an exemplary thermal control device according to some embodiments of the present invention. [Figure 33C] FIG. 2 is a model diagram of an exemplary thermal control device according to some embodiments of the present invention. [Diagram 34]FIG. 2 illustrates a thermal cycle with closed loop control according to some embodiments of the present invention. [Diagram 35] FIG. 1 shows 10 consecutive thermal cycles for the full range of PCR thermal cycling according to some embodiments of the present invention. [Figure 36A] FIG. 1 shows the thermal cycling performance for each of the five cycles at the beginning of thermal cycling and after two days of continuous thermal cycling. [Figure 36B] FIG. 4 is a control diagram of set points used in a control loop according to some embodiments of the present invention. [Figure 37] FIG. 2 is a diagram of set points used in a control loop according to some embodiments of the present invention. [Figure 38] FIG. 1 illustrates an example software architecture for a diagnostic assay system according to some embodiments of the present invention. [Figure 39] FIG. 2 is a logic diagram of software executed by a diagnostic assay system according to some embodiments of the present invention. [Diagram 40] FIG. 1 is a block diagram of a diagnostic assay system (Epsilon instrument core architecture) according to some embodiments of the present invention. [Figure 41-1] FIG. 2 illustrates various states of a hierarchical system machine (HSM) component according to some embodiments of the present invention. [Figure 41-2] FIG. 2 illustrates various states of a hierarchical system machine (HSM) component according to some embodiments of the present invention. [Figure 41-3] FIG. 2 illustrates various states of a hierarchical system machine (HSM) component according to some embodiments of the present invention. [Figure 41-4] FIG. 2 illustrates various states of a hierarchical system machine (HSM) component according to some embodiments of the present invention. [Diagram 42] FIG. 2 illustrates an instrument core internal components and interfaces according to some embodiments of the present invention. [Diagram 43]FIG. 2 is a block diagram illustrating software components executing on a mobile device in accordance with some embodiments of the present invention. [Diagram 44] FIG. 2 is a block diagram illustrating software components executed by a remote diagnostic reporting service according to some embodiments of the present invention. [Diagram 45] FIG. 1 is a data flow diagram showing top-level data flow in a diagnostic assay system according to some embodiments of the present invention. [Figure 46] FIG. 46 is a data flow diagram illustrating an embodiment of data flow in more detail than FIG. 45, showing components of the mobile device separately. [Figure 47] FIG. 1 is a data flow diagram illustrating a location configuration process for a diagnostic assay system, according to some embodiments of the present invention. [Figure 48] FIG. 1 is a data flow diagram illustrating a process for providing operational updates to a mobile device in a diagnostic assay system according to some embodiments of the present invention. [Figure 49] FIG. 1 is a data flow diagram illustrating a process for providing operational updates to a diagnostic device in a diagnostic assay system, according to some embodiments of the present invention. [Figure 50] FIG. 1 is a data flow diagram of such a process in a diagnostic assay system, according to some embodiments of the present invention. [Figure 51] FIG. 1 is a data flow diagram illustrating a process for performing diagnostic device commands in a diagnostic assay system according to some embodiments of the present invention. [Figure 52] FIG. 1 is a data flow diagram illustrating a process for registering a medical diagnostic device onto a network of a diagnostic assay system according to some embodiments of the present invention. [Figure 53] FIG. 2 is a diagram of a computer system according to some embodiments of the present invention that can be at least partially implemented into the devices and components of the diagnostic assay systems described herein. [Figure 54]FIG. 1 is a flow diagram of a method for managing a diagnostic assay system with a mobile device according to some embodiments of the present invention. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0034] I. System Overview
[0035] 1A shows a perspective view of a system 10 for testing biological samples, in accordance with an embodiment of the present invention. The compact form factor of system 10 provides a portable sample testing device capable of wireless or direct (wired) communication with a local computer or cloud-based network. As such, system 10 can be advantageously used in point-of-care applications, including mobile diagnostic centers, emerging markets, and physicians' offices.
[0036] The system 10 can be used with disposable assay cartridges that are configured to accommodate biological samples and fit a particular assay run. The system and cartridges are highly flexible and can be used to detect a variety of analytes, including nucleic acids and proteins. Non-limiting examples of analytes that can be detected using the system and assay cartridges include bacteria, viruses, and disease-specific markers for a variety of pathogenic disease conditions, including health-related infections (MRSA, Clostridium difficile, vancomycin-resistant Enterococcus (VRE), Norovirus), serious infectious diseases (MTB / RIF, Flu, RSV, EV), sexual health (CT / NG, GBS), oncology (e.g., breast cancer, bladder cancer), and genetics (FII / FV). In some embodiments, the system 10 can identify the type of cartridge through integrated near-field wireless communication capabilities (e.g., RFID, laser scanning) and then apply the appropriate assay routine to the cartridge. In some embodiments, cartridges can be identified using Bluetooth technology, RFID tags, bar codes, QR labels, and the like.
[0037] Once the assay cartridge is physically inserted into the system 10 and initialized, in some embodiments the system performs sample processing functions which may include sample preparation, nucleic acid amplification, and analyte detection processes. The results of the detection process can be uploaded wirelessly or directly by wire to a local computer or cloud-based network. Advantageously, the local computer may be a wireless communication device such as a tablet or cell phone with a software application specifically designed to control the system and communicate with the network.
[0038] The system 10 can be powered by an external power source, but can have an uninterruptible power source (e.g., a battery) in case of a power outage or site use. An uninterruptible power supply (UPS) allows site use of the system and in some embodiments can power the system for at least one day, and preferably up to two days. In some embodiments, the UPS allows for up to four hours of continuous operation. As shown in this external view, the system 10 can include an outer shell 12 and a door 14 for receiving an assay cartridge (not shown). The outer shell 12 can be configured in different styles as required by a particular user. Typically, the outer shell 12 is formed of a substantially rigid material, such as a hardened polymer or metal structure, to protect and support the internal components. In some embodiments, not shown here, the outer shell 12 can be fully reinforced (armored) for site use or decorative for use in a doctor's office, as shown here.
[0039] 1B is an exploded view of the major subsystems of system 10 (without the hull) from the outside. An overview of the subsystems is provided below. Further details of each subsystem are provided in the following sections.
[0040] Various subsystems are disclosed that utilize brushless DC (BLDC) motors. Typically, each motor has a stator assembly mounted on a printed circuit board (PCB) and can include a back-drivable variable speed mechanism such as a lead screw. In some embodiments, such BLDC motors utilize analog sensors (e.g., Hall sensors) to determine angular position and a force-based current monitor as a triggering tool. Such BLDC motors can include a rotor with multiple magnets disposed thereon, and at least as many sensors are mounted on the stator on the board as there are phases of the motor. The three sensors are positioned such that the rotor displacement is controllable based on the linear portion of the measurements from the sensors. This provides improved resolution and granularity without requiring the use of position sensors or encoder hardware. As such, the BLDC motors described herein do not require the use of encoder hardware, and their associated drive trains do not require position sensors. For example, the system can include a syringe drive mechanism 16 that includes a brushless BLDC motor with an output shaft that is mated to a back-drivable lead screw. The lead screw drives a plunger rod that interfaces to a plunger tip of a removable assay cartridge. Such a syringe drive mechanism 16 may share the PCB 30 with the door drive mechanism 18. The door drive mechanism also includes a BLDC motor having an output shaft that mates with a reversible lead screw. Although the motors for the syringe drive mechanism 16 and the door drive mechanism 18 are shown mounted directly on opposite sides of the PCB board, this is not essential and both motors could be mounted on the same side. In some embodiments, each motor could be mounted on its own PCB. The use of such BLDC motors is advantageous because the increased resolution and granularity improves accuracy and efficiency, and allows for further miniaturization of mechanisms driven by such motors. However, it should be understood that the use of such BLDC motors is not required and any of the mechanisms described herein could be driven by conventional motors if desired.However, in this case, additional sensors and / or circuitry may be required in some embodiments.
[0041] As noted above, BLDC motors are unique in that they include multiple Hall effect sensors but no traditional encoder hardware. In some embodiments, the syringe drive mechanism, door drive mechanism, and associated subsystems do not include position sensors. In some embodiments, the angular position of the rotor and output shaft of the BLDC can be derived solely from the sinusoidal output of analog sensors and circuitry on the PCB. Thus, traditional position sensors (e.g., encoders, optical sensors, etc.) do not need to be used with BLDC motors as used in the present invention. In order for BLDC motors to generate smooth torque, motor control techniques such as sinusoidal commutation can be implemented. Additionally, to achieve high speed operation, a pulse width modulation implementation can be used to center the drive voltage.
[0042] Additionally, because the lead screw of the mechanism is back-drivable, force-based end-of-travel detection can be used to determine the start and stop points of the mechanism drive. Force-based end-of-travel detection can be determined by monitoring the BLDC motor current, e.g., the current in a bridge circuit that deviates (increases or decreases) from normal when a force-based event occurs. This deviation can then be used to trigger the starting, stopping, reversing, slowing down, and / or accelerating of the BLDC motor. For example, in the case of a syringe drive mechanism 16, current sensing can be correlated to pressure and used to deliver a constant or deliberately varying pressure to the plunger rod by adjusting the RPM of the associated BLDC motor. This reduces the need for an in-line pressure sensor to monitor the cartridge pressure.
[0043] The valve drive mechanism 20 allows for a similar use of the same type of BLDC motor. In some embodiments, the valve drive mechanism 20 can include a worm drive gear train that provides the final output to the rotating platform, as does the valve drive that rotates the valve of the removable assay cartridge. In some embodiments, the worm drive mechanism is not back-drivable like the syringe drive and door drive mechanisms described above. However, the same type of Hall effect positioning and force-based triggering (current monitoring) can be used for this valve drive mechanism. For example, if a substantially smaller or larger current is unexpectedly required to rotate the valve drive, such an event can indicate a possible blockage or failure of the assay cartridge. Here, a force-based trigger can be used to sense a cartridge integrity failure.
[0044] The sonication horn mechanism 22 is partially integrated into the valve drive mechanism 20. The sonication horn 22 is capable of applying programmable ultrasonic power to the cartridge for a programmable duration, for example to lyse a target sample in the cartridge. In some embodiments, the sonication horn mechanism 22 can use a resonant piezoelectric actuator to impart vibrations at a frequency of about 30 kHz or more, or about 40 kHz or more, such as about 50 kHz (e.g., 50.5 kHz). The sonication horn mechanism 22 includes a control circuit that utilizes the phase of the measured current relative to the voltage excitation to determine the resonant frequency. The frequency is adjustable by the control circuit to maintain a preset phase relationship. In some embodiments, the amplitude of the voltage excitation is continuously adjustable to maintain a commanded power level. These features allow the control circuit to maximize the power output of the horn.
[0045] The system 10 also includes a door drive and cartridge loading system 24 that is driven by the door drive mechanism 18. A lead screw in the door drive mechanism 18 outputs power to the door drive and cartridge loading system 24 to open and close the door 14 and to engage and accept the assay cartridge 32.
[0046] The rear chassis section 26 and the front chassis section 28 provide structural support for the system 10 and mountings for other subsystems. The chassis sections are generally elongated to reduce the overall footprint of the system 10 and to make the system 10 portable. In some embodiments, the system has a footprint of 9.1"x3.0"x4.2" and an approximate weight of 2.2 pounds. An elongated circuit board or PCB 30 generally matches the footprint of the chassis sections. The PCB 30 includes most or all of the processor, sub-processor, memory, and control circuitry required to control the system 10. However, the aforementioned BLDC motors may be integrated on their own respective printed circuit boards with the control circuitry separately connected to the PCB 30. The PCB 30 also includes a portion of communication circuitry (e.g., near field communication circuitry, USB, wireless) as well as power circuitry.
[0047] The system 10 is compatible with various types of assay cartridges 32 that are generally configured to receive and hold samples of substances such as bodily fluids (e.g., blood, urine, salvia) or liquid-soluble solids (e.g., soil, spores, chemical residues). The assay cartridge 32 may be a walled structure having one or more fluid channels and connection ports. The assay cartridge 32 may be relatively small so as to be easily handheld, portable, and / or disposable. Examples of such cartridges (usable in the system 10) are disclosed in U.S. Pat. No. 6,660,228, WO2014052671A1, and U.S. Pat. No. 6,374,684, which are incorporated herein by reference for all purposes.
[0048] The assay cartridge 32 may include a reaction vessel 33 extending out from the rear, which interfaces with a thermal cycling and detection module 34. Module 34 includes one or more devices for delivering energy to and removing energy from a face of the assay cartridge 32. Such devices may include dual thermoelectric coolers. Module 34 also includes one or more detection aspects, as discussed in more detail below.
[0049] II. Brushless DC (BLDC) motor configuration
[0050] 2A is a plan view showing elements of a brushless DC (BLDC) motor 100 used in some embodiments of the present invention. Further details of BLDC motors can be found in commonly assigned U.S. Provisional Patent Application No. 62 / 195,449, filed July 22, 2015, entitled "Simple Centroid Implementation of Commutation and Encoding for DC Motor," which is hereby incorporated by reference for all purposes.
[0051] In one aspect, a BLDC motor includes a rotor and a stator configured to generate a smoothly varying Hall effect voltage without filtering or noise rejection. In some embodiments, this feature is provided by using a permanent magnet in the rotor that extends a distance beyond the magnetic core of the stator. In some embodiments, a BLDC motor includes as many Hall effect sensors as there are phases of the motor, positioned such that the motor is controllable based substantially solely on linear portions of the measured voltage waveforms received from the sensors. In some embodiments, this includes radially spacing the sensors around the stator such that the linear portions of the measured voltage waveform intersect. For example, a three-phase BLDC can include three Hall effect sensors radially spaced 40 degrees from one another, allowing the system to control the sensor positions within 40 degree increments.
[0052] In some embodiments, the motor includes an inner stator assembly 101 having nine pole teeth extending radially from a center, each pole tooth terminating in a pole piece 103, and each pole tooth having a winding forming an electromagnetic coil 102. The motor further includes an outer rotor 104 having an outer cylindrical skirt 105 and twelve permanent magnets 106 arranged in alternating polarity around the inner circumference of the skirt 105. The permanent magnets are shaped to give the rotor a cylindrical inner surface adjacent the outer curved surface of the pole pieces. The BLDC motor in this embodiment is a three-phase, twelve-pole motor. As known to those skilled in the art, control circuitry not shown in FIG. 2A switches current in the coils 102 to provide electromagnetic interaction with the permanent magnets 106, thereby driving the rotor.
[0053] It should be noted that the disclosure of the number of pole teeth and poles, as well as the inner stator and outer rotor, is exemplary and not limiting as the present invention is operable with a variety of different motor designs.
[0054] FIG. 2B is a side elevational view, partially in section, of the motor of FIG. 2A. One of nine pole teeth and coils are shown cut away and terminating at a pole piece 103 adjacent one of twelve permanent magnets 106 arranged around the inner circumference of a cylindrical skirt 105 of an outer rotor 104. The pole teeth and pole piece of the stator assembly 101 are part of the core and define the distal end of the core at the level of the line 204. The stator assembly 101 is supported on a substrate 201 in this implementation, which in some embodiments is a printed circuit board, and may include a control unit and traces configured to operate the switching of current to the coils 102 to provide an electromagnetic field that interacts with the magnetic field of the permanent magnets 106 to drive the rotor. The substrate PCB may also include control circuitry for encoding and commutation. The rotor 104 is physically engaged to the stator 101 by a drive shaft 107. The drive shaft engages a bearing assembly of the stator to precisely rotate the rotor. The drive shaft 107 in this implementation is purposely passed through an opening in the PCB 107 so that it can engage a driving mechanism.
[0055] Three linear Hall effect sensors 202a, 202b, 202c are shown in FIG. 2B supported by substrate 201 and strategically positioned to generate a variable voltage signal that can be used in a process to encode and commutate motor 100 according to some embodiments of the present invention. In FIG. 2B, the overall height of skirt 105 of rotor 104 is represented by dimension D. Dimension d1 represents the extension of the distal end of the rotor magnets below the distal end of the core at line 204. In a conventional motor, there is no reason or incentive to extend this end below the end of the core, especially since this would increase the height of the motor and require a large gap between the rotor and substrate. In fact, the added dimension would add unnecessary cost and volume to a conventional motor, so a skilled engineer would limit dimension D to eliminate such an extension. Furthermore, at the distal end of the rotor of a conventional motor, the effect of a large magnetic field is created by current switching in coils 102 at or above the level of the core, and the signal detected by a Hall effect sensor positioned to sense a permanent magnet at that location does not produce a smoothly varying Hall effect voltage. Instead, the effect in a conventional motor is substantially corrupted by noise. The conventional solution to this dilemma is the introduction of noise filtering, or more commonly, the use of an encoder.
[0056] Extending the rotor magnet below the distal end of the iron core avoids the degrading effect of the switching magnetic field from the stator coil on the signal detected by the Hall effect sensor. The specific extension d1 depends on several factors specific to a particular motor configuration, and in some embodiments, the extension is 1 mm or more (e.g., 2 mm, 3 mm, 4 mm, 5 mm, 6 mm, or more), and in some embodiments, the extension is less than 1 mm. In some embodiments, the distance is a function of the size of the permanent magnet and / or the magnetic field strength. In some embodiments detailed herein, an extension of 1 mm is sufficient to generate a sinusoidal signal of voltage change without noise or saturation. Placing the Hall effect sensor at a distance d2 to generate the Hall effect voltage generates a smooth variable voltage without noise. In some embodiments, the Hall effect sensor generates a smooth variable DC voltage in the range of about 2 volts to about 5 volts without noise or saturation. The dimension d2 can vary depending on the sensor selection, the rotor design, the strength of the permanent magnets in the rotor, and other factors known to those skilled in the art. A workable distance for avoiding saturation of the sensor and producing a substantially noise-free smoothly varying DC voltage can be easily found for any particular situation.
[0057] Figure 2C is a plan view of a portion of substrate 201 taken in the direction of arrow 3 in Figure 2B. It shows the placement of Hall effect sensors 202a, 202b, 202c relative to the distal end of rotor 104, which in Figure 2B can be seen to extend a dimension d1 below the distal end of the core. In Figure 2C, the rotational path of rotor 104, which includes twelve permanent magnets 106, is shown in dotted outline 302. The rotor rotates in either direction 303 depending on the commutation details.
[0058] As shown in this non-limiting exemplary embodiment, each Hall effect sensor 202a, 202b, 202c is positioned just below the distal end of the rotor magnet and slightly radially inward of the central orbit of the rotating magnet. Hall effect sensor 202b is located 40 degrees arc from Hall effect sensor 202a along the rotor magnet's rotational orbit. Similarly, Hall effect sensor 202c is another 40 degrees around the rotor orbit from Hall effect sensor 202b.
[0059] FIG. 2D shows three voltage waveforms 401, 501, 601 generated by the permanent magnet 106 of the rotor 104 passing over the Hall effect sensors 202a, 202b, 202c in a three-phase BLDC motor. The sinusoidal variable voltage waveform 401 is generated by the permanent magnet 106 of the rotor 104 passing over the Hall effect sensor 202a. The starting point of 0 degrees is arbitrarily set to the maximum voltage point. Three complete sinusoidal waveforms are generated in one complete 360 degree rotation of the rotor. The voltage waveform 501 is generated by the permanent magnet 106 of the rotor 104 passing over the Hall effect sensor 202b. Furthermore, a substantially noise-free sinusoidal variable voltage waveform 501 is generated by the permanent magnet 106 of the rotor 104 passing over the Hall effect sensor 202b. Hall effect sensor 202b is located 40 arc degrees from the location of Hall effect sensor 202a, and sinusoidal waveform 501 is phase shifted by 120 degrees from the phase of sinusoidal waveform 401. Additionally, a substantially noise-free sinusoidal variable voltage waveform 601 is generated by passing permanent magnet 106 of rotor 104 over Hall effect sensor 202c. Hall effect sensor 202c is located 40 arc degrees from the location of Hall effect sensor 202b, and sinusoidal waveform 601 is phase shifted by 120 degrees from the phase of sinusoidal waveform 501. The waveform is repeated every 360 degrees of rotor rotation.
[0060] The three voltage waveforms 401, 501, 601 each have substantially identical maximum and minimum peaks because the Hall effect sensors are identical and sense the same leakage magnetic field at the same distance. Furthermore, the waveforms 401, 501, 601 cross at multiple points, examples of which are points 402, 502, 602. In particular, it can be seen that the portions of the waveforms between the crossing points are substantially straight lines, providing an infinite continuous sequence of connected straight line segments. Furthermore, the zero crossing points of each straight line segment, as well as the maximum and minimum peaks of each waveform, can be detected and recorded.
[0061] FIG. 2D further shows two straight line segments between nodes 402, 502, and 602. As a non-limiting example, the segment between nodes 402 and 502 is shown divided into 20 segments of equal length. This can be conveniently done by detecting the voltage at nodes 402 and 502 and simply dividing it. Since the rotor's physical rotation from one node of the waveform to the next is 20 degrees of motor rotation, each calculated voltage change is 20 / 20, or 1.00 degree of rotor rotation. This is a relatively rough example that is merely used to illustrate the method. In some implementations of the invention, circuitry on PCB 201 detects the nodes and divides between them with an 11-bit analog-to-digital converter (ADC). This gives 2048 counts. In this implementation, the mechanical rotational displacement of rotor 205 for each count is approximately 0.0098 degrees. Using an ADC with higher (or lower) bit resolution can increase (or decrease) the resolution of the system. For example, using an 8-bit ADC resolves one count to approximately 0.078 degrees, a 16-bit ADC resolves one count to 0.00031 degrees, a 20-bit ADC resolves one count to approximately 0.00002 degrees, etc. Alternatively, by increasing or decreasing the number of poles, the resolution of the system will correspondingly increase or decrease.
[0062] In some embodiments, the present invention provides a high degree of accuracy and precision to mechanisms driven by motor 100. In the non-limiting example above, using an 11-bit ADC, the motor position can be mechanically controlled to 0.0098 degrees. Combined with gear reduction, this allows for extremely fine control of the translation and rotation of the mechanism. In some embodiments, motor 100 is coupled to the translation driver of a syringe pump unit that draws and dispenses fluids in a diagnostic process.
[0063] FIG. 2E illustrates an electrical circuit for motor 100 control in one embodiment of the present invention. This utilizes the output of the Hall effect sensors and a unique method of analyzing only the linear portion of the phase separated curve generated by the sensors, which is divided into equal segments as described above. The output of the Hall effect sensors 202a, 202b, 202c are provided to a Proportional Integral Derivative (PID) motion control circuit for commutation purposes, and the waveform generated by the interaction of the rotor magnets and the Hall effect sensors is provided to a multiplexing circuit as shown in FIG. 2E. As described above in the non-limiting exemplary embodiment, an ADC is used to segment the linear portion of the phase separated waveform, and the motor 100 can be driven by, for example, a Texas Instruments motor drive circuit DRV8313. Those skilled in the art will appreciate that the circuitry is not necessarily unique and that other circuit configurations may be used while still remaining within the scope of the present invention. In some embodiments, the circuitry and coded instructions that sense the Hall effect sensors and provide the motor encoding may be implemented in a programmable system on chip (PSoC) on a PCB. The circuit can also include a torque estimation circuit that can be provided to estimate the torque generated by the motor based on the current and voltage measurements taken by the PSoC, thus avoiding the need for additional force sensors throughout the larger system.
[0064] III. Motor torque evaluation
[0065] In some embodiments, aspects of the BLDC motor 100 and control circuitry can be used to sense torque without the need for external sensors. This can be accomplished in a variety of ways, but for example, as represented in the model shown in Figure 3A, by evaluating torque based on the principle that the power input to a BLDC motor is equal to the power dissipated in the motor (i.e., copper losses) plus the mechanical power extracted from the motor. This principle is quantified by the following equation:
number
[0066] Here, the power consumption P CL is calculated as follows:
number
number
[0067] Referring to the power balance equation above, it logically follows that:
number
[0068] Substituting the power variables, we obtain the following equilibrium equation:
number
[0069] From this, the motor torque τ m Solving this, we obtain the following equation:
number
[0070] Now, there are two possible solutions for the motor torque, the most positive and the most negative torque solutions, obtained from the previous equation, and the bridge current i B It is expressed as follows using
number
[0071] If the torque can be calculated from the motor constants and other variables, then the motor constant K t It is also possible to calculate the motor torque using
number
[0072] As a result, (K t (using τ m The solution τ closest to the calculated value of m1 ^ or τ m2 ^ is considered to be the correct solution. The following table defines the above variables. [Table 1] [Table 2]
[0073] Based on the above principles, torque values can be estimated based on easily obtained current and voltage measurements. This can be accomplished using low-cost programmable system-on-chip integrated circuits, such as the PSoC series of circuits sold by Cyprus Semiconductor Corp. Additional variables such as friction can be accounted for using, for example, a Kalman filter, as can cogging effects resulting from harmonic disturbance torques. As will be appreciated by those skilled in the art, the ability to use low-cost, simple integrated circuits for torque estimation is a significant advantage over conventional devices that rely on sensors (pressure sensors, encoders, etc.) to provide feedback to the device, resulting in a reduction in the number of parts required and overall system cost. This advantage is realized to a great extent when torque detection is used as a command trigger, as shown below in the door opening and cartridge loading, syringe actuation, and valve actuation subsystems.
[0074] IV. Door Opening and Cartridge Loading Subsystem
[0075] In another aspect, the present invention provides a door opening and cartridge loading subsystem driven by a back-drivable mechanism to facilitate manual loading and unloading of assay cartridges into a diagnostic assay system. In some embodiments, the door opening mechanism and cartridge loading system are integrated to provide a coordinated action such that manual loading of a cartridge into an open bay of the system initiates closure of the bay door, typically upon detection of back-driving of the mechanism as a user manually pushes the cartridge into the system. It will be appreciated that such a mechanism can be driven by a BLDC motor as described herein and can utilize motor torque estimation, or can utilize a variety of conventional motors and techniques known to those skilled in the art. Examples of such configurations are detailed below.
[0076] 4A shows a perspective view of the door opening and cartridge loading subsystem 100. The system includes the brushless DC (BLDC) motor 100 described above mounted on a PCB 30'. The BLDC motor 100 includes an output shaft (not shown) to which a lead screw 109 is attached. The lead screw 109 is the back-drivable portion of a transmission that operates to open and close the door 14 and also transmits power to the cartridge loading mechanism.
[0077] The lead screw 109 threads into a nut on the bridge 108 so that when the lead screw 109 rotates, the bridge 108 moves either upwards or downwards (when the device is oriented as shown in FIG. 4A) depending on the direction of rotation of the lead screw 109. A first rack portion 110 and a second rack portion 112 are attached to the bridge 108. Both rack portions are elongated and include a rack 114 and a cam track 116 which is an "L" shaped track.
[0078] A pair of pinion gears 118 mesh with the rack 114. Movement of the bridge 108 and lead screw 109 causes the rack 114 to move up and down, which in turn causes the pinion 118 to rotate. The pinion gears 118 are interconnected by a common shaft 120 supported on a subframe 122, which is attached to a larger portion of the system 10, such as the rear chassis section 26. Each pinion gear 118 includes a finger 124 to stop the rotation of the pinion gear 118 at a particular interface.
[0079] Each pinion gear 118 is integral with a larger door gear 126. Therefore, the pinion gears 118 and the door gear 126 rotate at the same RPM. The door gears 126 cooperate with a door rack 128 of the door 14. Therefore, as the door gear 126 rotates, the door rack 128 and the door 14 move up or down depending on the direction of rotation of the door gear 126.
[0080] 4B-4E illustrate the method of loading an assay cartridge. In FIG. 4B, a command is sent to the BLDC motor 102 to open the door 14 and position the system to receive insertion of the cartridge 32. When the command is received, the system 100 operates the BLDC motor 102 to rotate the lead screw 109. This action moves the bridge 108 and its attached rack members 110 / 112 upward, thereby initiating rotation of the pinion gear 118 and door gear 126. This motion causes the door 14 to move upward as the door gear 126 rotates relative to the door rack 128.
[0081] After the door 14 is fully open, the pinion gear 118 disengages from the racks 114 of the first and second rack portions 110 / 112 which continue to move upward. The upward movement of the first and second rack portions 110 / 112 also actuates the cartridge loading arm 130 by virtue of the pin 132 which is constrained to move along the cam path 116 of the first and second rack portions 110 / 112. This movement causes the cartridge loading arm 130 to rotate about the pivot 134 which places the first arm portion 136 in an upward position.
[0082] The first and second rack portions 110 / 112 move upward until a force-based event occurs that causes the lead screw 109 to back-drive. Such an event may be, for example, the bridge 108 hitting a stop or the first and second rack portions 110 / 112 pulling on the cartridge load arm 130. The back-drive event is detectable as a change in current in the bridge circuit of the BLDC motor. Based on the back-drive event, the BLDC motor is commanded to stop rotating and come to a stop in the position shown. Advantageously, this step is performed without the aid of a position sensor.
[0083] 4C, the assay cartridge 32 is inserted into the system 10 until a portion of the assay cartridge 32 contacts the first arm portion 136. A slight movement relative to the first arm portion 136 results in another back-drive event in the lead screw 109 that is detectable as a current change in the bridge circuit of the BLDC motor. This event acts as a command to the BLDC motor to reverse direction from the previous door opening step to capture the cartridge and close the door.
[0084] As shown in FIG. 4D, the upward movement of the first and second rack portions 110 / 112 guides the pin 132 around the length of the cam path, which in turn causes the cartridge loader arm 130 to rotate clockwise. This causes the second arm portion 138 of the cartridge loader arm 130 to push the cartridge inward to the home position. Additionally, the first and second rack portions 110 / 112 are raised such that the fingers 124 of the pinion gear 118 rotate through the notches 140 of the first and second rack portions 110 / 112. This initiates movement of the pinion gear 118 relative to the rack 114, as well as movement of the door gear 120 relative to the door rack 128. In this manner, downward movement of the door 14 occurs toward the closed position.
[0085] Continuing movement of the lead screw 109 causes the door 14 to move downward until the door is fully closed, as shown in FIG. 4E. The BLDC motor is powered in this manner until a backdrive force-based event occurs on the lead screw 109. The backdrive event may be, for example, the bridge 108 hitting a stop or the first and second rack portions 110 / 112 pushing against the cartridge load arm 130. The backdrive event is detectable as a change in current in the bridge circuit of the BLDC motor. Upon detection of the backdrive event, the BLDC motor is commanded to stop rotating and come to a stop in the position shown. Advantageously, this step is performed without the aid of a position sensor.
[0086] V. Syringe Drive Subsystem
[0087] As previously mentioned, embodiments of the present invention may include aspects of syringe drive mechanism 16. As shown in Figure 5A, syringe drive mechanism 16 includes the previously described BLDC motor 200. BLDC motor 200 includes an output shaft connected to a back-drivable lead screw 209.
[0088] The laterally extending arm 206 includes a nut that threads onto a lead screw 209. The laterally extending arm 206 is also attached to a plunger rod 208. By commanding the BLDC motor 200 to rotate the lead screw 209 in the appropriate direction, the laterally extending arm 206 and plunger rod 208 can be driven up and down.
[0089] After the assay cartridge 32 is secured and the door 14 is closed, the syringe drive mechanism 16 is available to interface with the assay cartridge 32. The assay cartridge includes a syringe passageway 210 which holds a plunger tip 212. By moving the plunger rod 208 downwardly into the syringe passageway 210, the tip of the plunger rod 208 engages the plunger tip 212. The combined plunger tip 212 and plunger rod 208, together with the syringe passageway, thus act as a syringe to pressurize and depressurize the assay cartridge 32. Programmed pumping of the assay cartridge 32 causes fluid to flow in and out of the various chambers of the assay cartridge 32 to perform the assay.
[0090] After engaging the plunger tip 212, the plunger rod 208 is actuated by the BLDC motor 200 to allow movement to any desired position within the syringe passage 210, including implementing various syringe pumping algorithms. The current of the BLDC motor 200 is continuously monitored to allow a constant pressure to be delivered to the plunger rod, thus reducing the need for an in-line pressure sensor to monitor the cartridge pressure.
[0091] Thus, the lead screw 209 can be back-driven, decreasing the pressure in the assay cartridge 32, causing the fixed plunger rod 208 to pull down. A decrease in pressure can be detected by monitoring the measured current of the BLDC motor 200, detecting the relative change, and varying the output of the BLDC motor 200 accordingly. Similarly, a decrease in pressure in the assay cartridge 32 can cause the fixed plunger rod 210 to push up. An increase in pressure can be detected by monitoring the measured current of the BLDC motor 200, detecting the relative change, and varying the output of the BLDC motor 200 accordingly. Advantageously, this can be accomplished without the aid of a pressure sensor.
[0092] In another example, the current flowing through the moving plunger rod 208 can be monitored for changes indicative of an increase or decrease in pressure rate. Thus, after detecting the relative change, the output of the BLDC motor 200 can be varied to increase or decrease the pressure rate imparted by the moving plunger rod 208. Advantageously, this can be accomplished without the aid of a pressure sensor.
[0093] One example of a method 220 for determining proper loading of an assay cartridge and the integrity of its testing using the principles of monitoring the BLDC current described above is shown in Figure 5B. Assume that the assay cartridge 32 has already been physically loaded, as shown in Figure 5A.
[0094] In operation 222, a command is sent to begin the loading procedure. As a result, in operation 224, a force limit is set. The force limit is the maximum force that the BLDC motor 200 can apply to the plunger rod 208 for this operation, which is related to the plunger rod 208 pressing the plunger tip 212 to the bottom of the syringe passage 210. In operation 226, the BLDC motor 200 is actuated to move the plunger rod 208 into the syringe passage 210 and engage the tip of the plunger rod 208 with the plunger tip 212. In operation 228, the torque of the BLDC motor 200 is continuously monitored using the torque evaluation circuit of FIG. 2E and the method of FIGS. 3A-3C to determine if the plunger rod 208 has moved to the bottom of the syringe passage 210. If the force limit has not been exceeded, in operation 230, the loading procedure is determined to have failed. Sometimes, the plunger tip 212 may be missing due to a manufacturing error or physical defect. In either case, the plunger rod 208 reaches the end of its travel in the syringe passageway 210 without properly impinging on the plunger tip 212, and therefore the force limit is not exceeded.
[0095] If the upper force limit is exceeded, it is determined that the plunger rod 208 has pressed the plunger tip 212 against the bottom of the syringe passageway 210, and the method 220 moves to operation 232 where a lower force limit is set. The lower force limit is the maximum force that the BLDC motor 200 will apply to the plunger rod 210 for this operation, which is related to depressurizing the plunger tip 212. In operation 234, the BLDC motor 200 is actuated to move the plunger rod 210 upward in the syringe passageway 210. In operation 236, the torque of the BLDC motor 200 is continuously monitored to determine if the lower limit has been exceeded. As a result of operation 228, the plunger tip 212 is strongly pressurized. The lower limit is the amount of force required to depressurize the plunger tip, and is therefore zero for subsequent operations other than at the plunger tip 212 position. If the lower limit is exceeded, the BLDC motor 200 stops operating, and the method moves to operation 238. It is then determined whether the syringe has pulled a vacuum. In this operation, a valve in the assay cartridge 32 is actuated to seal off the syringe passageway 210 from the atmosphere, which was not done in the previous operation. After this is completed, the BLDC motor 200 is actuated to pull the plunger rod 208 upward against the vacuum in the syringe passageway 210. If the plunger rod 208 does not move freely and a force is detected, it is determined in operation 240 that a vacuum has been established and therefore the integrity of the assay cartridge 32 has not been compromised. If the plunger rod 208 moves freely without a force being detected, it is determined in operation 242 that a vacuum has not been established and therefore the integrity of the assay cartridge 32 has been compromised.
[0096] Another example of a method 248 utilizing the above-described principles of monitoring BLDC current to determine the initialization of the assay cartridge syringe (i.e., plunger rod 208, syringe passage 210, and plunger tip 212) is shown in Figure 5C. It is assumed that the assay cartridge 32 has already been physically loaded as shown in Figure 5A, and that the cartridge is properly loaded as shown in Figure 5B.
[0097] In operation 250, a command is sent to begin the loading procedure. As a result, in operation 252, a force limit is set. The force limit is the maximum force that the BLDC motor 200 can exert on the plunger rod 208 for this operation, which is related to placing the plunger tip 212 in the proper upward position (with respect to the orientation of the device as shown in FIG. 5A) at the top of the syringe passageway 210.
[0098] In operation 254, the BLDC motor 200 is actuated to move the plunger rod 208 upward within the syringe passage 210, thereby causing the plunger tip 212 to be uppermost at a position within the syringe passage 210. In operation 256, the torque of the BLDC motor 200 is continuously monitored using the torque estimation circuitry of FIGURE 2E and the method of FIGURES 3A-3C.
[0099] If the upper force limit is exceeded, the plunger tip 212 is determined to be at the top and the method 248 moves to operation 258 where a lower force limit is set. The lower force limit is the maximum force that the BLDC motor 200 can apply to the plunger rod 210 for this operation, related to forcing the plunger tip 212 to the bottom of the syringe passageway 210, without over pressurizing the plunger tip 212. In operation 260, the BLDC motor 200 is activated to move the plunger rod 210 downwardly within the syringe passageway 210. In operation 262, the torque of the BLDC motor 200 is continuously monitored to determine if the lower force limit set in operation 258 has been exceeded. If the limit is exceeded, the BLDC motor 200 is stopped and the plunger tip 212 is considered to be already located at the bottom of the syringe passageway 210. The method 248 then moves to operation 238 where it is determined whether the syringe has moved a predetermined distance (e.g., 60 mm). This is accomplished by utilizing a Hall effect sensor in the BLDC motor 200 to count the revolutions of the lead screw 209 and relate the count to the linear travel of the syringe rod 208. In some cases, the upper and lower force limits are triggered by an obstruction or excessive friction in the syringe passage 210. Therefore, a travel check step is performed to ensure that the syringe rod 208 has moved freely without obstruction. If the syringe rod 208 has moved at least the predetermined travel, then the initialization is determined to be successful in operation 266. However, if the syringe rod 208 has not moved at least the predetermined travel, then the initialization is determined to be unsuccessful in operation 268.
[0100] VI. Valve Actuation Subsystem
[0101] As previously mentioned, embodiments of the present invention may include aspects of the valve drive mechanism 20. As shown in Figures 6A and 6B, the valve drive mechanism 20 includes the BLDC motor 300 previously described.
[0102] The BLDC motor 300 is mounted to a chassis 304 having a number of reinforcing ribs 306 that contribute to the stiffness of the chassis 304. The chassis 304 includes an elongated first portion 307 that provides a mount for a stator 308 of the BLDC motor 300. An elongated shaft 310 extends from the BLDC motor 300 and carries a first worm 312. The first worm 312 engages and rotates a first worm gear 314 which in turn rotates on a common shaft 316 with a second worm 318.
[0103] The second worm 318 engages and rotates a second worm gear 320. The second worm gear 320 is integral with a turntable valve actuator 322, which is configured to engage with a rotary valve mechanism of the assay cartridge 32. The valve actuator 322 is mounted to an elongated second portion 324 of the chassis 304. The elongated second portion 324 includes a passageway 325 for engaging with the sonication horn mechanism 22.
[0104] In use, the BLDC motor 300 is powered and rotates, thereby rotating the valve actuator 322 via the worm drive described above. The valve actuator 322 is effectively geared down, allowing for high accuracy in the positioning of the valve actuator 322. No position sensor is included in the syringe drive mechanism 16, as the angular position of the stator 308 is determined solely from the sinusoidal output of the Hall effect sensor, and the position of the valve actuator can be determined from this, given the final gear ratio.
[0105] The worm drive is not back-drivable like the syringe drive and door drive described above. However, the same type of Hall effect positioning and force-based triggering can be used for this valve drive. Here, the force-based trigger can indicate a cartridge integrity failure. For example, if a substantially smaller or larger current is unexpectedly required to rotate the valve drive, such an event can indicate a possible blockage or failure of the assay cartridge. Although each of the syringe drive, door drive and valve drive mechanisms have been described as utilizing the improved BLDC motors described herein, it will be understood that any or all of the drives and mechanisms could utilize conventional BLDC motors, servo motors or other suitable motors, as will be appreciated by those skilled in the art. However, additional sensors or circuitry may be required in some cases.
[0106] Additionally, the BLDC motor is configured to home and center the valve drive output by implementing a centering protocol based on the sinusoidal signal generated by the Hall effect sensor. This compensates for gear backlash and gear wear over time. This is illustrated in the graph of the Hall voltage signal versus valve drive position shown in Figure 6C. As shown, a given position of the valve drive 322 can change due to gear backlash and wear.
[0107] VII. Horn Sub-Assembly
[0108] In some embodiments, an ultrasonic horn assembly is provided for use in the diagnostic assay systems described herein. In some embodiments, the ultrasonic horn assembly includes an ultrasonic horn, a horn housing, a spring, a chassis, and control circuitry for operating the horn. The horn housing is adapted to support and secure the ultrasonic horn and includes a spring coil retaining section for facilitating movement of the horn between disengaged and engaged positions, and a wedge for interfacing with a cam mechanism of the system for actuating movement of the horn between disengaged (lowered) and engaged (raised) positions. Although a coil spring is described herein, it will be understood that various other types of springs or biasing mechanisms can be used. In the disengaged position, the tip of the ultrasonic horn is flush or below a base surface on which the assay cartridge sits to facilitate loading and unloading of the assay cartridge from the system. In the engaged position, the tip of the ultrasonic horn is above the base surface and engages a dome of the sonication chamber of the assay cartridge to facilitate sonication of biological material in a fluid sample contained within the sonication chamber during preparation and / or processing of the sample analysis. In some embodiments, movement of the horn is accomplished by an actuator mechanism common to one or more other movable components of the system, such as a door of the system. The horn assembly also includes electrical circuitry, such as a printed circuit board having an interface adapted to be electrically connected to corresponding electrical circuitry in the system to facilitate operation of the ultrasonic horn by the system.
[0109] In some embodiments, the diagnostic assay system is positioned upright during the performance of the assay (as shown in Figures 9A-9B), such that the horn moves between a disengaged position (lowered from the cartridge) and an engaged position (raised towards the cartridge) to engage and contact the sonication chamber of the cartridge. It will be appreciated that in some embodiments designs may vary and the horn may have a variety of other orientations and / or positions relative to the cartridge in the disengaged and engaged positions depending on the design of the cartridge and the diagnostic assay system.
[0110] VII.A. Design and Construction of Horn Subassembly
[0111] Figure 7A shows an ultrasound horn subassembly 700 configured for use in a diagnostic assay system according to some embodiments of the present invention. Figure 7B shows an exploded view of the horn assembly of Figure 7A. In this embodiment, the horn subassembly includes an ultrasound horn 710, a horn housing 720, a spring coil 730, a control circuit 740, and a chassis 750. The horn subassembly can be tested as a stand-alone subassembly prior to insertion into a system, and can be removed and replaced as needed.
[0112] 8A-8E show the components of the horn assembly at various stages of assembly. As shown in FIG. 8A, an ultrasonic horn 710 is snap-fitted into a horn housing 720 (shown cut away to show the horn inside). The housing can be designed such that snapping the horn into the housing positions or fixes the horn in a predetermined orientation and position with respect to the housing. For example, an ultrasonic horn may be designed to include a portion that is not perfectly axisymmetric about the horn's longitudinal axis such that a corresponding portion or surface on the interior of the housing engages to secure the horn within the housing and inhibit rotation of the horn therein. Axially asymmetric portions may include, but are not limited to, flats on one or both sides of the horn, protrusions or tabs extending outwardly from the horn, or contacts with which the horn makes electrical contact, etc.
[0113] In some embodiments, the horn 720 is incorporated into a subassembly and is controlled by a control circuit to provide an appropriate output for lysis of the biological material required for a particular assay.
[0114] As seen in Figure 8A, the exterior surface of the horn housing 720 includes a spring retaining portion 722 that retains the spring coil 730 to move the housing 720 between the disengaged and engaged positions. The retaining portion includes upper and lower retaining surfaces 722a and 722b that engage the spring when it is in an uncompressed state. The housing 720 may also include one or more lead retention details 723 to secure and / or guide the lead to electrically connect to the horn 710 as the horn moves between the disengaged and engaged positions. The horn housing 720 includes a wedge portion 721 that interfaces with a cam in the system.
[0115] As shown in FIG. 8C, the partially assembled horn assembly can be snapped into a horn chassis 750. The chassis has localized portions 751 that engage corresponding portions of the housing 720 to fix its position and orientation when the housing is snapped into place. The chassis also includes one or more features for securing the entire horn assembly 700 within a diagnostic assay system, for example, a base portion with one or more holes that allow the chassis to be attached to a module. In some embodiments, the chassis is formed of a polymer material by injection molding. However, it will be understood that the chassis can be formed of a variety of other materials (e.g., polymers, ceramics, metals) by a variety of other manufacturing processes (e.g., pressing, machining, etc.). After the horn assembly is placed in the chassis, the circuit component 740 is attached to the chassis. The chassis may include one or more mounting portions 752a by which a circuit component (e.g., a PCB) can be secured by one or more fasteners or screws 752b. The circuit component can be electrically connected to the horn before or after it is attached to the chassis. The completed horn assembly 700 can then be inspected and supplied to a user either individually or within a diagnostic assay system.
[0116] VII.B. Sonication Horn Positioning Interface
[0117] In some embodiments, the ultrasonic horn is attached to a movable mechanism, whereby the ultrasonic horn is positioned relative to a sonication chamber of an assay cartridge disposed within a diagnostic assay system. In some embodiments, the assay cartridge includes a sonication chamber disposed at the bottom of the cartridge (when oriented as in FIG. 10A ) that has a downwardly facing dome (the outer surface of the dome is convex with respect to the assay cartridge) as shown in the example of FIG. 10A , which corresponds to the rounded tip 711A of the dome-shaped output portion 711 of the ultrasonic horn. Although the tip is rounded in this embodiment, the tip of the dome portion may have a variety of shapes, including but not limited to flat, pointed, concave, convex, round, and hemispherical, as desired. The dome-shaped portion of the sonication chamber and the rounded horn tip focus the ultrasonic energy delivered from the horn to efficiently reach the desired ultrasonic levels required to lyse cellular material (e.g., fibronectin cells, spores, etc.) and release DNA into the fluid sample with minimal ultrasonic horn power and size requirements. Preferably, the rounded tip 711a of the dome-shaped output portion 711 of the ultrasonic horn presses against the dome 1211 of the ultrasonic treatment chamber 1210 with sufficient force to ensure that contact between the tip of the horn and the dome-shaped surface of the ultrasonic treatment chamber is maintained throughout the delivery of ultrasonic energy. In some embodiments, the movable mechanism is configured to move the ultrasonic horn upward (in the engagement direction) to press the dome of the ultrasonic treatment chamber and the dome of the ultrasonic horn together and into engagement with a force of at least 0.5 lbf. In some embodiments, the force applied to secure the rounded tip of the horn and the dome of the ultrasonic treatment chamber is between about 1 lbf and about 2 lbf. In some embodiments, the force applied is about 1.4 lbf. Although interfacing cams and wedges are described herein, it will be appreciated that various other mechanisms may be used to facilitate movement of the horn between the disengaged and engaged positions, with or without a biasing member. For example, in some embodiments, such mechanisms may include lead screws, cables, and the like.
[0118] In some embodiments, the movable mechanism that positions the ultrasonic horn to press against the sonication chamber is integrated into a connector-to-connector network of actuators that move various other components of the diagnostic assay system, such as opening and closing doors to the system, loading and unloading assay cartridges from the system, moving valve assemblies and syringe assemblies within the system, etc. It will be understood that the movable mechanism may be integrated with actuators of one or more other components or the movable mechanism may be completely independent of the other mechanisms and actuators.
[0119] Figures 9A-9B are cross-sectional views of a diagnostic assay system during and after loading of an assay cartridge into the system, showing the mechanism for positioning the ultrasound horn in conjunction with closing the system door and loading of the assay cartridge. Figure 9A shows the assay cartridge 32 partially inserted, with the distal facing portion of the base of the assay cartridge beginning to engage the ejection teeth of the eject / load cam 1120. In this position of the cam 1120, the outer surface of the cam engages the upper surface 721 of the wedge portion 721 of the horn housing. This can be seen in more detail in the side and cross-sectional views of Figures 11A-1 and 11A-2.
[0120] As the assay cartridge 32 is inserted more fully, it presses against the ejection teeth and the eject / load cam 1120 rotates clockwise, causing the loading teeth of the cam to engage the underside of the assay cartridge and pull the cartridge inwardly towards the fully loaded position. As the eject / load cam 120 rotates, the outer surface 1121 of the cam slides along the wedge tip 721a of the wedge portion 721 of the horn housing slide. This presses the horn housing away from the cartridge towards a disengaged position and partially compresses the spring coil 730. When the assay cartridge is fully inserted, the wedge tip 721a fits within the inner curve 1121a of the rounded portion of the cam 1120. This causes the horn housing 720 to move upwards a short distance and at least partially restores the coil so that the rounded tip 711a of the ultrasonic horn projects along it above the surface where the assay cartridge was loaded and presses into engagement with the dome shaped portion of the sonication chamber. This position is shown in more detail in side and cross-sectional views in Figures 11B-1 and 11B-2, respectively. As can be seen in Figures 9A and 9B, the rotation of the cam 120 is actuated by a closing movement of the first rack portion 110 of the door rack mechanism, which in this embodiment is a downward movement (in the direction of the arrow). Through a network of interrelated gears, this closing movement of the door also simultaneously acts to close the door 100 of the system 1000 from the open position of Figure 9A, which facilitates insertion and loading of the assay cartridge 32, to a closed position as shown in Figure 9B after loading. Movement of the door rack mechanism can be effected by one or more motors such as any of those described herein.
[0121] FIG. 10A shows a cross-sectional view of an assay cartridge for use in a diagnostic assay system according to some embodiments of the present invention. The dome-shaped portion 1211 of the sonication chamber 1210, as described above, is disposed on the bottom surface of the assay cartridge. The sonication chamber 1210 is in fluid communication with the channel network of the assay cartridge through which fluid is transported by moving valves and syringes to achieve pressure changes during the assay procedure. After sample conditioning and / or processing, the conditioned fluid sample is transported into a chamber of a reaction vessel 33. An excitation means and an optical detection means are then used to optically detect the presence or absence of a target analyte (e.g., nucleic acid) of interest (e.g., bacteria, viruses, pathogens, toxins, or other target analytes). It will be appreciated that such a reaction vessel may include a variety of different chambers, conduits, and microwell arrays for use in detecting the target analyte. An example of the use of such a reaction vessel for the analysis of a fluid sample is described in commonly assigned U.S. Patent No. 6,818,185, entitled "Cartridge for Conducting a Chemical Reaction," filed May 30, 2000, the entire contents of which are incorporated herein by reference for all purposes.
[0122] VII.C. Ultrasonic Processing Horn Control
[0123] In some embodiments, the ultrasonic horn is operated using a horn control circuit configured to control current amplitude and phase estimation to optimize the excitation required for a particular assay and provide a stable and robust delivery of ultrasonic power proportional to current at a fixed voltage. In some embodiments, the system provides full digital control of the delivery of sonication power. In some embodiments, the system provides operation of the ultrasonic horn without conventional transformers and full wave rectifying analog circuitry, thereby allowing for reduced power usage, reduced horn assembly size, and reduced overall system size. In some embodiments, the power delivery and control is provided to control the active power (as opposed to reactive power) to the ultrasonic horn, which is total power. The control circuit is configured to apply programmable sonication power to the assay cartridge for programmable durations to lyse the target cells required for a particular assay.
[0124] In some embodiments (see, e.g., FIG. 12A), the ultrasonic horn includes a mass 713 (typically a solid core made of metal) adjacent one or more piezoelectric actuators 714 that vibrate when connected to a power source 716 via electrical contacts 715. The solid mass includes a tapered section 712' that focuses the ultrasonic waves and leads to an elongated section 712 that terminates in a dome-shaped output section 711 that further focuses the ultrasonic waves for output at a tip 711a of the dome-shaped output section 711. In general, multiple piezoelectric actuators can be used to provide greater ultrasonic power output at lower relative specifications (compared to a single actuator suitable for delivering high ultrasonic energy).
[0125] In some embodiments, the horn assembly is available with a horn control circuit that operates an off-the-shelf horn in a closed loop or feedback controlled manner. This control provides stable and robust ultrasonic energy at desired levels with relatively lower power specifications than would otherwise be available for the horn. For example, such off-the-shelf horns with multiple piezoelectric actuators may not operate stably by simply applying a set current level because the actuators operate out of phase when activated to deliver ultrasonic energy levels suitable for lysing cells in a diagnostic assay. The piezoelectric actuators expand outward when current is applied, and if this outward expansion occurs even slightly differently (out of phase), low frequency coupling into the vibrations occurs, preventing the horn from delivering ultrasonic energy at the proper level. Thus, such horns may only operate properly at lower ultrasonic levels or may not be relied upon to provide stable energy delivery for the duration required for a particular diagnostic assay.
[0126] In some embodiments, the system employs an improved control scheme to enable the consistent delivery of ultrasonic energy levels suitable for lysing cells in diagnostic assays over a particular duration using a horn as described above. In some embodiments, the horn assembly is configured to apply vibrations at about 50.5 kHz using a resonant piezoelectric actuator. In some embodiments, the horn assembly is configured to apply a vibration frequency in the range of about 20 kHz to about 50 kHz. For example, the vibration frequency may be about 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, or 50 kHz. In some embodiments, the vibration frequency is greater than 50 kHz. In some embodiments, the system utilizes a closed loop control system to provide piezoelectric excitation and maintain it in phase with each other for the duration required for sonication of biological material.
[0127] In some embodiments, the system applies current and / or voltage to the piezoelectric actuator by ramping the applied power to a desired level to minimize the occurrence of out-of-phase excitation. An example of this scheme is shown in FIG. 10B. In some embodiments, power delivery and control is performed to control the real power (as opposed to reactive power) to the ultrasonic horn (which is total power). By substantially maintaining a specific phase relationship between voltage and current, reactive power can be substantially eliminated. Reactive power would exist if the piezoelectric actuator were not phase locked and the horn simply vibrated. By ramping the power, as opposed to simply applying power, the system maintains the phase relationship between current and voltage and prevents vibration, allowing delivery of the desired ultrasonic energy level required by the horn.
[0128] FIG. 12B shows a simulated horn power transfer function illustrating the phase relationship between excitation current and voltage at power resonance.
[0129] In some embodiments, the horn control circuit uses closed control loops for the operation of the horn. In the inner control loop, the frequency is adjusted to maintain the current phase relationship. In the outer loop, the amplitude of the voltage excitation is continuously adjusted to maintain the commanded power level. Examples of these inner and outer control loops are shown in FIG.
[0130] FIG. 13 is a diagram of a control scheme for a sonication horn assembly, according to some embodiments of the present invention. The sonication interface is configured with the power (watts) and duration (seconds) required for a particular assay. A typical power level of 5-10 watts is applied for between 15-30 seconds to sufficiently lyse a typical spore cell and release ~50% of the spore-bound DNA in the solution in the sample chamber 1210 as shown in FIG. 10B. However, it should be understood that the power, duration, and desired sonication efficiency vary from assay to assay and may be greater or less than the levels described depending on the assay requirements, design, and type of cells or material being sonicated. In some embodiments, the PSoC DAC generates a 0-4V sine wave. The DAC output goes out through a TI audio amplifier. The TI amplifier amplifies the signal by 20 dB. The TI amplified signal goes through a step-up transformer before being delivered to the horn. The power is estimated from the voltage (DAC voltage amplified through the TI and transformer) and the current read by the sensor (P=v*Icos(Φ)) (active power). Thus, the power delivered to the horn is controlled by controlling the DAC voltage. A control loop drives the input voltage to maintain the power at the desired level. See for example Figure 15.
[0131] In some embodiments, the horn control circuit is configured such that the frequency that gives the highest effective power amplitude from the frequency sweep is established as the resonant frequency. The phase between the input voltage and the output voltage is measured at the resonant frequency. During sonication, the control loop fixes the measured phase between the input voltage and the output voltage by adjusting the input frequency. The current amplitude is the product of the sensor coefficient and the PSoC amplifier, which amplifies the signal before reading it. An exemplary relationship between power and input voltage is shown in FIG. 16. An exemplary relationship between horn current amplitude and phase versus frequency is shown in FIG. 17.
[0132] In some embodiments, the horn control circuit utilizes sinusoidal control to control the amplitude input to the horn driver. The circuit can utilize phase control for resonant frequency control to ensure that the voltage and current are maintained in a particular phase relationship that can be used, for example, to eliminate reactive power. In some embodiments, the circuit utilizes a frequency sweep with 1 Hz resolution, although it is understood that the configuration can provide effectively unlimited frequency resolution. Such a configuration allows for the delivery of stable and robust ultrasonic energy levels using ultrasonic horns with reduced power and size specifications than would otherwise be possible for such devices.
[0133] VIII. Thermo-Optical Subassembly
[0134] In some embodiments, the present invention provides a thermal optical subassembly (TOS) for use in a diagnostic assay system. In some embodiments, the TOS includes a thermal controller component and an optical excitation / detection component. The TOS can interface with other components of the diagnostic assay system, including ultrasonic horns, doors, syringes, and valves. In some embodiments, the TOS includes a thermal controller device and an optical component device having excitation means and optical detection means. The TOS unit is configured to define a cavity into which a reaction vessel can be inserted for performing nucleic acid amplification and / or detection of a target analyte using the thermal controller component and optical interrogation of the target analyte using the optical component device. The TOS is used in a system having one or more wiring boards (e.g., motherboards) that control the operation and coordination between the various components of the assay system. In some embodiments, the Cellcore resides on the motherboard. In some embodiments, each hardware subassembly has its own dedicated PSoC processor and associated electronics. In some embodiments, the diagnostic assay system includes a communication means (e.g., wireless, NFC, USB) that allows the control software or control parameters utilized by the system to be modified and / or updated. The TOS also includes one or more sensors (e.g., an NFC reader) for determining the position or presence of an assay cartridge or the position of a valve component to coordinate the operation of multiple components of the system. In some embodiments, the TOS includes a cartridge position sensor (e.g., an NFC reader) physically located on the TOS to enable the TOS to be in physical proximity to the assay cartridge when inserted into the diagnostic assay system. In some embodiments, the TOS is serially connectable to other electronic subsystems via USB and / or a wireless interface such as NFC or Bluetooth.
[0135] VIII.A.TOS Design
[0136] It is understood that the thermal control device and the optical detection device can be configured in various configurations as desired. In the embodiments described herein, the thermal control and optical detection devices are configured for use with a reaction vessel having two opposing major surfaces and two ends (minor surfaces). The thermal control device can be configured for single-sided heating, where one major surface of the reaction vessel is heated, or double-sided heating, where both major surfaces are heated. In the embodiments described herein, the thermal control device is configured to be disposed adjacent to one or both sides of one major surface of the reaction vessel. Similarly, the optical detection device can be configured according to various configurations, such as optical detection from one major surface of the reaction vessel or one or more ends (minor surfaces) of the reaction vessel. In general, the optical detection configuration corresponds to the thermal control device configuration, for example, the optical detection device is configured to detect the optical system through the portion of the reaction vessel that is not covered by the thermal control device. In some embodiments where single-sided heating is used, the opposite, unheated major surface can be covered with a transparent insulating material for heat transfer control, while still allowing optical detection through the insulating material. In some embodiments, the system utilizes a thermal control device configured for single-sided heating and an optical detection device configured to excite / detect from one major surface and / or one or more ends (minor surfaces) of the reaction vessel. In other embodiments, the system utilizes a thermal control device in a double-sided heating configuration with an optical detection device configured to excite / detect from one or more ends of the reaction vessel. Exemplary configurations are shown below.
[0137] FIG. 18 illustrates an exemplary diagnostic assay system 1000 for detecting a target analyte in a prepared fluid sample in a disposable assay cartridge (not shown) inserted into the system. The diagnostic assay system 1000 includes several components and subassemblies as described herein, one of which is a TOS subassembly 1100. As shown in FIG. 18, the TOS subassembly 1100 can be installed from the front of the system. The TOS can be inserted into the frame or housing of the system 1000 with the door 14 open and secured with one or more screws (not shown) so that the front plate 1110 faces into the receptacle of the system that houses the assay cartridge. The front plate 1110 defines a hollow opening or slot 1111 through which the planar reaction vessel of the assay cartridge can be inserted. In some embodiments, the TOS can be tested as a stand-alone subassembly prior to insertion into the diagnostic assay system. In some embodiments, the TOS can be removed or replaced as needed.
[0138] In some embodiments, the diagnostic assay system uses a disposable assay cartridge. An example of an assay cartridge suitable for use with the systems described herein is described in U.S. Patent No. 6,818,185, filed May 30, 2000, entitled "Cartridge for Conducting a Chemical Reaction," the entire contents of which are incorporated herein by reference for all purposes.
[0139] In some embodiments, the TOS slot 1111 and cavity are sized to accommodate a reaction vessel (typically within ±0.020"), and the optical mount and associated components position optical components relative to the reaction vessel to facilitate excitation and optical detection of target analytes. In some embodiments, the TOS positions a thermal control device, such as a dual TEC device, relative to the reaction vessel to control and facilitate thermal cycling of a fluid sample in the reaction vessel of the assay cartridge. In some embodiments, the TOS moves the thermal control device, for example retracting the dual TEC prior to insertion into the reaction vessel, and then engaging and clamping the dual TEC to the reaction vessel once the reaction vessel is in place.
[0140] 19A and 19B are front and rear views of an exemplary TOS subassembly 1100 according to some embodiments of the present invention. FIG. 19A shows an exemplary reaction vessel 33 inserted into a cavity opening 1111 of a front plate 1110. Also shown are a thermal control mount / heat sink 820, as well as a cooling fan 822 (see FIG. 20B). FIG. 19B shows a rigid-flex PCB and thermal contact mechanism 840 that allows the thermal control device to move laterally before clamping into the reaction vessel 33. PCBs 830 and 831 that provide power and control to the thermal control device 800 and the optical component 900 can be coupled via a rigid-flex connection 832 that allows for lateral movement. The thermal contact mechanism 840 includes a slidable component that translates between an open state (see FIG. 24B) and a clamped state (see FIG. 24A). In the clamped state, the TEC surface 810 of the thermal control device is engaged to the side of the reaction vessel 33. In some embodiments, the thermal contact mechanism 840 includes a movable and / or adjustable bracket 842 that moves up and down along a vertically extending mount 844 to ensure proper alignment with the optical component 900 and the reaction vessels, and that can move laterally towards the thermal control device to ensure suitable thermal contact with the reaction vessels 33 to facilitate efficient thermal cycling. In some embodiments, the thermal contact mechanism 840 includes a bottom support or guide 846 to facilitate insertion of the reaction vessels into the thermal contact mechanism 840, and in some embodiments, this movement is accomplished by axial movement of the door drive rack 110, as shown in FIGS. 26A-26B.
[0141] 20A-20B are exploded views of an example of a TOS according to some embodiments of the present invention. As can be seen, the TOS assembly includes an optical mount 930 having a window through which the excitation component 910 and the optical detection component 920 can operate when assembled. The optical mount is attached to a front plate 1110 via a bracket 1113 and at least partially surrounds a flange 1112 around a reaction vessel opening 1111. The thermal control device 800 is coupled to the optical mount 930 by two pins 834 that extend through a thermal contact mechanism 840 and two holes that pass through the optical mount 930. The assembly may also include a sensor for detecting the proximity or individual characteristics of the position of the cartridge in the system. In some embodiments, the sensor is a near field communication (NFC) sensor 1190. However, it is understood that various other sensors may be used. It is also understood that in some embodiments, the NFC may be adapted to detect a variety of different things. These include, but are not limited to, cartridge location / presence, cartridge type, specific assay, microfluidic procedures specific to a particular assay, presence of a mobile device (e.g., PDA), and various other lot-specific parameters. In some embodiments, NFC enables workflows related to specific systems / cartridges, thereby eliminating the need for separate databases in the cloud that diagnostic assay systems would otherwise need to access. This functionality is particularly useful in resource-limited settings where the internet is not readily available.
[0142] 21A-21B show optical components and associated PCBs of an exemplary TOS according to some embodiments of the present invention. The optical components include an excitation component 910, an optical detection component 920, and associated PCB components 830, 831, and electrical circuitry 833. In some embodiments, the PCBs are connected by rigid-flex connections 832, which allow the thermal control device to move laterally relative to the reaction vessel. FIGS. 22A-22B show the thermal control device components and associated PCBs with rigid-flex connections of an exemplary TOS. FIGS. 23A-23B show the thermal control device 800 prior to attachment to an optical mount 930 of an exemplary TOS. In some embodiments, the optical mount 930 includes an alignment feature 931 to ensure proper alignment between the optical components 900 and the reaction chamber portion of the reaction vessel 33. The alignment feature may include one or more features that engage with corresponding features on the reaction vessel. For example, a hole that receives a pin extending distally of the reaction tube, a protrusion or ridge that engages with a corresponding recess in the reaction vessel, a pair of magnets, any suitable feature that facilitates alignment between the reaction vessel and the optical component 900, etc.
[0143] 24A, 24B, and 25 show thermal control device components movably coupled to an optical mount and slide base according to some embodiments of the present invention. In some embodiments, the thermal control mechanism 840 presses into engagement with a reaction vessel of an assay cartridge. In some embodiments, the force applied to engage the thermal control device with the reaction vessel is at least 1 lbf. In some embodiments, the amount of force used to ensure that the TEC surface is held parallel to and in sufficient contact with the major surface of the reaction vessel 33 is between 1 and 3 lbf, typically about 1.3 lbf of clamping force. FIGS. 26A and 26B show the operation of the door rack 110 to laterally move the thermal control device between the clamped and open positions (see FIGS. 24A and 24B, respectively).
[0144] Figure 28 shows a schematic diagram of an optical and thermal module assembly 810 of a TOS according to some embodiments of the present invention. The optical module includes a detection block chip or detection component 920 and an excitation block chip or excitation component 910 disposed on a PCB carrier. Figure 28 shows an exemplary TOS for use in the diagnostic assay systems disclosed herein.
[0145] VIII.B. Optical Components
[0146] FIG. 30A shows an exemplary optical component configuration for use with the diagnostic assay system disclosed herein. FIG. 30B shows a detailed schematic diagram of an exemplary optical component configuration, according to some embodiments of the present invention. In some embodiments, the optical excitation and detection means operate through a minor surface (end) of the reaction vessel of the assay cartridge, while the thermal control device engages one or more opposing major surfaces of the reaction vessel. In some embodiments, the thermal control device component thermally engages one side of the major surface of the reaction vessel. In some embodiments, the thermal control device component thermally engages both sides of the major surface of the reaction vessel. This latter configuration may be particularly useful for heating and cooling larger volumes of fluid samples. Such a configuration may use a ceramic plate heater for heating and a means for passive cooling (e.g., blowing ambient air over a ceramic heater) to perform thermal cycling of the fluid in the reaction vessel, or may include any of the TEC configurations described herein.
[0147] According to some embodiments of the invention, as in the configuration shown in FIG. 30B, a small LED excitation chip can excite the fluid sample through the minor end of the reaction vessel, while a small detection chip collects the fluorescence through the major face of the reaction vessel 33. Additionally, the dual TEC design provides controlled heating and cooling through the opposing face, providing improved temperature control compared to passive cooling as used in some thermal cyclers. In some reaction vessels, such as the configuration in FIG. 30A, the window looking into the end is narrow (approximately 1.0 mm x 4.5 mm), and this small size makes traditional lensing difficult. By collecting the fluorescence from the major face of the reaction vessel, as in FIG. 30B, a larger detection window can be obtained, allowing a larger signal to be collected while keeping the excitation and detection orthogonal to each other. In some embodiments, the optical detection chip is sized to fit the dimensions of the reaction vessel. FIG. 30C shows a detailed view of an exemplary excitation block and detection block, respectively, according to some embodiments of the invention. As shown, excitation block 910 includes an LED light source 911 that directs light through filter and lens 912 and rod lens 913 to emit light of a desired wavelength at a desired location in reaction vessel 33. Optical detection block 920 includes a photodiode detector 921 that detects light emitted from reaction vessel 33. The emitted light passes through rod lens 923 and filter and lens 922 before being received by photodiode 921 to ensure that a particular wavelength that may be indicative of a response corresponding to the presence of a target analyte in reaction vessel 33 is detected.
[0148] In some embodiments, the optical components 900 include an optical excitation component 910 and an optical detection component 920 disposed on an optical mount adapted to accommodate the planar reaction vessel 33. The optical excitation component 910 is disposed to emit excitation energy through the edge (minor surface) of the planar surface of the reaction vessel 33, and the optical detection component 920 is disposed along the major planar surface of the reaction vessel. In one aspect, the optical excitation component and the optical detection component are orthogonal to each other. In some embodiments, the optical components are configured to utilize lenses with high numerical apertures. In some embodiments, the optical components are configured to operate at low numerical apertures without the need for the use of lenses. In such embodiments, the light path may run from the light source through a filter to the detection component without the need for the use of lenses to focus the light generated by the excitation. Some embodiments can be configured such that the excitation and detection light paths are disposed away from each other to improve detection of the light generated by the excitation at low numerical apertures without the need for lenses. Using such spatial separation for excitation light detection allows for lens-free light detection, thereby enabling a small system size.
[0149] In a fluorescence detection system, the excitation light is generally larger than the amount of emitted fluorescence signal. To efficiently detect the emission signal, it is important to collect as much of the emitted light as possible. Therefore, most conventional systems use a high numerical aperture for the optical detection system. A high numerical aperture allows more light to be collected, thereby resulting in higher resolution. On the other hand, a low numerical aperture generally collects less light, resulting in lower resolution. Most conventional fluorescence optical detection systems use a setup that includes a lens and a bandpass filter in the light path between the light source and the detector. The filter is generally placed between the lens and the detector, and the lens allows the collimated light to pass through the filter. Without the lens (and collimated light), the efficiency of the filter would be reduced because light that hits the bandpass filter at high angles of incidence would simply pass through unfiltered. The lens eliminates this problem by collimating (reducing the high angle of incidence beam) and providing more efficient filtering of the excitation wavelengths.
[0150] In some embodiments of the present invention, the optical system does not include lenses. In the absence of lenses, a low numerical aperture configuration is used in which the optical path includes only a light source, a bandpass filter, and a detector. The use of a low numerical aperture in this configuration improves filtering efficiency by reducing high angle of incidence light (without the use of lenses). As a result, most of the excitation wavelengths are filtered out, resulting in a strong emission signal.
[0151] In some embodiments, the optical module includes UV, blue, green, yellow and red LEDs, associated optical filters, coupling optics, and protective glass. In some embodiments, the optical device is fully encapsulated in epoxy, providing protection from impact and protection against ingress of dust and moisture. In some embodiments, the optical excitation and detection chips are small in size, such as less than 10 mm in each dimension, typically about 5 mm (length) x 4 mm (width) x 3 mm (height).
[0152] FIG. 31 is a detailed view of excitation block 910 and detection block 920 showing the relative areas of adjacent reaction vessels through which light is emitted from the excitation block and collected by the detection block.
[0153] 32 illustrates fluorescence detection with excitation and detection components of an optical component according to some embodiments of the present invention. As can be seen, the configuration of FIG. 32 is consistent with the arrangement pattern of excitation and detection blocks involved in using low numerical aperture according to some embodiments.
[0154] VIII.C. Thermal Control Device
[0155] VIII.C.1. Overview
[0156] FIG. 27 is a block control diagram of a thermal controller 800 in a TOS board according to some embodiments of the present invention. In some embodiments, the thermal controller includes dual thermoelectric coolers (TECs) with a thermal capacitor disposed between them. In some embodiments, the thermal controller uses closed loop control utilizing two thermistors to control the operation of each TEC to optimize heating and cooling of the reaction vessel or active surface engaging the vessel. This configuration provides lower noise, improved temperature stability, higher gain and higher bandwidth compared to the control of conventional temperature controllers. In some embodiments, one thermal controller is used to heat / cool the fluid sample through a major surface of the reaction vessel. In some embodiments, the fluid sample is heated / cooled through both major surfaces of the reaction vessel using a thermal controller for each major surface of the reaction vessel.
[0157] In any of the above embodiments including a first and a second thermoelectric cooler, the second thermoelectric cooler can be replaced with a thermal manipulation device. Such a thermal manipulation device can include any heater (e.g., a thermal resistance heater), cooler, or any means suitable for temperature regulation. In some embodiments, the thermal manipulation device is included in a common microenvironment with the first thermoelectric cooler such that the temperature of the microenvironment is altered relative to the ambient temperature by the action of the thermal manipulation device. In this aspect, the device alters the ambient environment to cause the first thermoelectric cooler to cycle between a first temperature (e.g., an amplification temperature between 60-70° C.) and a second elevated temperature (e.g., a denaturation temperature of about 95° C.) as rapidly as possible. If both the first and second temperatures are higher than the true ambient temperature, it is more efficient for a second heat source (e.g., a thermoelectric cooler or heater) in the microenvironment to raise the temperature in the microenvironment above the ambient temperature. Alternatively, when the ambient temperature exceeds the second elevated temperature, the thermal manipulation device may cool the microenvironment to an ideal temperature to more effectively rapidly cycle between the first and second temperatures.
[0158] In some embodiments, the thermal control apparatus includes a first thermoelectric cooler having an active surface and a reference surface, a thermal manipulation device, and a controller operably coupled to each of the first thermoelectric cooler and the thermal manipulation device. The controller operates the first thermoelectric cooler in conjunction with the thermal manipulation device to increase the efficiency of the first thermoelectric cooler as the active surface temperature of the first thermoelectric cooler changes from an initial temperature to a desired target temperature. The thermal manipulation device may include a thermal resistive heating element, or a second thermoelectric cooler, or any suitable means for temperature regulation.
[0159] In some embodiments, the thermal control apparatus further includes one or more temperature sensors coupled to the controller and disposed along or near the first thermoelectric cooler, the thermal manipulation device, and / or a microenvironment common to the first thermoelectric cooler and the thermal manipulation device, the thermal manipulation device being thermally coupleable to the first thermoelectric cooler through a microenvironment defined within the diagnostic assay system, where the thermal manipulation device is configured to enable a temperature of the microenvironment to be controlled and adjusted from an environmental temperature external to the system.
[0160] In some embodiments, the thermal control device includes a controller coupled to each of the thermoelectric cooler and the thermal manipulation device, which is configured to temperature control to control a temperature within a chamber of a reaction vessel in thermal communication with the thermal control device. In some embodiments, the controller is configured to operate the first thermoelectric cooler based on thermal modeling of an in situ reaction chamber temperature within the reaction vessel. The thermal modeling can be performed in real time, and can utilize Kalman filtering depending on the accuracy of the model.
[0161] In some embodiments, the thermal control device is disposed within a device of a diagnostic assay system and is in thermal communication with a reaction vessel of an assay cartridge disposed within the system, and the controller is configurable to perform thermal cycling of a polymerase chain reaction process within the chamber of the reaction vessel.
[0162] In some embodiments, the thermal control device includes a thermoelectric cooler having an active side and a reference side, a thermal manipulation device, a thermal interposer disposed between the first thermoelectric cooler and the thermal manipulation device such that the reference side of the first thermoelectric cooler is thermally coupled to the thermal manipulation device via the thermal interposer (which may be a thermal capacitor as disclosed herein), and a first temperature sensor adapted to detect a temperature of the active side of the first thermoelectric cooler. The device may further include a controller operably coupled to each of the thermoelectric cooler and the thermal manipulation device. The controller operates the thermal manipulation device in conjunction with the first thermoelectric cooler to increase the speed and efficiency of the first thermoelectric cooler as the active side temperature of the first thermoelectric cooler changes from an initial temperature to a desired target temperature. In some embodiments, the controller is configured in a closed control loop having a feedback input of a predicted temperature based on a thermal model that includes an input from the first temperature sensor.
[0163] Various aspects of such thermal control devices are described in detail in co-filed U.S. Provisional Patent Application No. ___, entitled "Thermal Control Device and Methods of Use," Attorney Docket No. 85430-1017353-011410US, the entire contents of which are incorporated herein by reference for all purposes. It will be understood that thermal control devices used in TOS systems according to some embodiments of the present invention may include any combination of the elements described therein.
[0164] VIII.C.2.TEC design
[0165] In some embodiments, the thermal control device includes a first TEC having an active surface and a reference surface, a second TEC having an active surface and a reference surface, and a thermal interposer disposed between the first and second TECs such that the reference surface of the first TEC is thermally coupled to the active surface of the second TEC via the thermal interposer. In some embodiments, the thermal interposer acts as a thermal capacitor. In some embodiments, the thermal control device includes a controller operatively coupled to each of the first and second TECs. The controller is adapted to operate the second TEC simultaneously with the first TEC to increase the speed and efficiency of operation of the first TEC as the temperature of the active surface of the first TEC changes from an initial temperature to a desired target temperature. In some embodiments, the first and second thermoelectric coolers are thermally coupled via a thermal capacitor having sufficient thermal conductivity and mass to transfer and store thermal energy to reduce the time when switching between heating and cooling to provide faster and more efficient thermal cycling. In some embodiments, the device utilizes a thermocouple in a first thermoelectric cooler device and another thermocouple in a thermal capacitor layer, and operates utilizing first and second closed control loops based on the respective temperatures of the first and second thermocouples. The second control loop may be configured to lead or lag the first control loop to utilize the thermal energy stored in the thermal capacitor layer. Utilizing one or more of these aspects described herein, embodiments of the present invention provide a faster and more robust thermal control device for performing rapid thermal cycling, preferably in about 2 hours or less, even in the problematic high temperature environments discussed above.
[0166] In some embodiments, the thermal control device includes a thermal capacitor made of a thermally conductive material with sufficient mass to store thermal energy to sufficiently facilitate switching speed between thermal cycles and increased efficiency in heating and cooling the TEC. In some embodiments, the thermal capacitor includes a material having a higher thermal mass than the active and reference surfaces of the first and second TECs, which can be made of a ceramic material. In some embodiments, the thermal capacitor is made of a copper layer having a thickness of about 10 mm or less (e.g., about 10, 9, 8, 7, 6, 5, 4, 3, 2, or 1 mm or less). This configuration allows for a relatively thin, planar structure of the thermal control device, making it suitable for use in the reaction vessels of a nucleic acid analysis device with a small size.
[0167] In some embodiments, the thermal control device includes a first temperature sensor adapted to detect a temperature of an active surface of the first TEC and a second temperature sensor adapted to detect a temperature of the thermal capacitor. In some embodiments, the first and second temperature sensors are coupled to a controller such that operation of the first and second TECs is based at least in part on respective inputs from the first and second temperature sensors to the controller. In some embodiments, the second temperature sensor is embedded in or at least in thermal contact with the thermally conductive material of the thermal capacitor. It will be appreciated that in any of the embodiments described herein, the temperature sensors may be located in a variety of other locations so long as the sensor is in sufficient thermal contact with an individual layer to detect the temperature of that layer.
[0168] In some embodiments, the thermal control device includes a controller configured with a primary control loop provided with an input from a first temperature sensor and a secondary control loop provided with an input from a second temperature sensor. The controller can be configured to provide a bandwidth response of the primary control loop that is faster (or slower) in timing than the bandwidth response of the secondary control loop. Typically, both the first and second control loops are closed loops. In some embodiments, the controller is configured to cycle between a heating cycle in which the active surface of the first TEC is heated to a high target temperature and a cooling cycle in which the active surface of the first TEC is cooled to a low target temperature. The controller can be configured for the second control loop to switch the second TEC between a heating mode and a cooling mode before the first control loop switches between heating and cooling to thermally charge the thermal capacitor. In some embodiments, the second control loop maintains the temperature of the thermal capacitor within about 40° C. of the temperature of the active surface of the first TEC. In some embodiments, the second control loop maintains the temperature of the thermal capacitor within about 5, 10, 15, 20, 25, 30, 35, 40, 45, or 50° C. of the temperature of the active surface of the first TEC. The controller can be configured such that the efficiency of the first TEC is maintained by operation of the second TEC such that heating and cooling of the active surface of the first TEC occurs at a temperature ramp rate of about 10° C. / sec. Non-limiting exemplary ramp rates achievable with the present invention include 20, 19, 18, 17, 16, 15, 14, 13, 12, 11, 10, 9, 8, 7, 6, 5, 4, 3, 2, or 1° C. / sec. In some embodiments, the high temperature target temperature is about 90° C. or higher and the low temperature target temperature is about 40° C. or lower. In some embodiments, the high temperature is about 95° C. and the low temperature target temperature ranges from about 60° C. to about 75° C., including both ends of that range and all temperatures therebetween.
[0169] In some embodiments, the thermal control device further includes a heat sink coupled to the reference surface of the second TEC to prevent thermal runaway during cycling. The thermal control device may be constructed in a generally planar configuration and sized to correspond to a planar reaction chamber portion of a reaction vessel of an assay cartridge. In some embodiments, the planar size has dimensions of about 45 mm or less in length and about 20 mm or less in width, or about 40 mm by about 12.5 mm, e.g., about 11 mm by 13 mm, making it suitable for use with a reaction vessel of a miniature PCR analyzer. The generally planar configuration may be configured to have a dimension of about 20 mm or less in thickness from the active surface of the first TEC to the heat sink facing surface. Advantageously in some embodiments, the thermal control device may be adapted to engage the reaction vessel on one side for thermal cycling of the reaction vessel, allowing optical detection of target analytes from the opposite side of the reaction vessel during thermal cycling.
[0170] In some embodiments, a temperature control method is provided herein. Such a method includes operating a first TEC having an active surface and a reference surface to heat and / or cool the active surface from an initial temperature to a target temperature, and operating a second TEC having an active surface and a reference surface to increase the efficiency of the first TEC as the active surface temperature of the first TEC changes from the initial temperature to a desired target temperature, where the active surface of the second TEC is thermally coupled to the reference surface of the first TEC via a thermal capacitor. Such a method further includes operating the first TEC including operating a primary control loop having a temperature input from a temperature sensor on the active surface of the first TEC, and operating the second TEC including operating a secondary control loop having a temperature input from a temperature sensor in the thermal capacitor. In some embodiments, the method further includes cycling between a heating mode in which the active surface of the first thermoelectric device is heated to a high temperature target temperature and a cooling mode in which the active surface is cooled to a low temperature target temperature, and storing thermal energy from the thermal oscillations between the heating mode and the cooling mode in the thermal capacitor. Here, the thermal capacitor comprises a layer having a high thermal conductivity relative to the active and reference surfaces of the first and second thermoelectric cooling devices, respectively.
[0171] In some embodiments, the method of temperature control in a thermal cycle includes cycling the second thermoelectric device between heating and cooling modes simultaneously with cycling the first thermoelectric device between heating and cooling modes, thereby maintaining efficiency of the first thermoelectric device during the cycle. In some embodiments, the controller is configured such that a bandwidth response of the primary control loop is faster than a bandwidth response of the secondary control loop. The controller can be further configured to time the cycle by the controller to switch between modes of the second thermoelectric device before switching between modes of the first thermoelectric device to thermally charge the thermal capacitor. In some embodiments, the high temperature target temperature is greater than or equal to about 95° C. and the low temperature target temperature is less than or equal to about 50° C. In some embodiments, the method of temperature control further includes maintaining a temperature of the thermal capacitor within about 40° C. of a temperature of an active surface of the first TEC by controlling operation of the second TEC during the cycle of the first TEC to maintain efficiency of the first TEC during the cycle. In some embodiments, the efficiency of the first TEC is maintained by operation of the second TEC such that heating and / or cooling of the active surface of the first TEC occurs at a temperature ramp rate of about 10° C. / sec or less, such methods further including operating a heat sink coupled to a reference surface of the second TEC during cycling of the first and second TECs to prevent thermal runaway.
[0172] In some embodiments, a method for thermal cycling in a polymerase chain reaction process is provided. Such a method may include engaging a thermal control device with a reaction vessel containing a fluid sample for performing a polymerase chain reaction to amplify a target polynucleotide, thermally engaging an active surface of a first TEC with the reaction vessel, and thermal cycling the thermal control device according to a specific protocol for amplifying the target polynucleotide in the fluid sample. In some embodiments, engaging the thermal control device with the reaction vessel includes engaging an active surface of the first TEC with one side of the reaction vessel leaving an opposite side uncovered by a thermal device to allow optical detection from the opposite side. In some embodiments, each of the heating mode and the cooling mode uses one or more operating parameters, and the one or more operating parameters are asymmetric between the heating mode and the cooling mode. For example, each of the heating mode and the cooling mode has a bandwidth and a loop gain, and the bandwidth and loop gain of the heating mode and the cooling mode are different.
[0173] In some embodiments, a method of controlling temperature in a thermal control device is provided. Such a method includes providing a first and a second TEC, each having an active side and a reference side, with a thermal capacitor therebetween, to the thermal control device, heating the active side, cooling the active side, heating the reference side, and cooling the reference side. In some embodiments, each of the heating of the active side and the cooling of the active side are controlled by one or more operating parameters. In some embodiments, the magnitude of the one or more operating parameters is different when heating the active side compared to when cooling the active side.
[0174] In some embodiments, the method includes reliability testing between a plurality of thermal control devices by use of an alternating fixture. Such a method includes alternating thermal cycling between the thermal control device and a second or other thermal control device, and performing thermal cycling of the second or other reaction vessels by manipulating a fixture that alternately positions the thermal control device and the second or other thermal control device in an active position where the thermal cycling of the respective reaction vessel is performed. In some embodiments, the fixture is a rotatable hub with the thermal control device and two or more thermal control devices distributed circumferentially around an exterior of the hub, and manipulating the fixture includes rotating the hub.
[0175] VIII.C.2.a. Examples of TEC Design Configurations
[0176] FIG. 33A shows an exemplary control device. It includes a first TEC 811 (main TEC) and a second thermal manipulation device, such as a second TEC 812 or thermal resistance element, thermally coupled through a thermal capacitor 813, also referred to as a thermal interposer. The TEC has an active surface 811a of the first TEC 811 thermally coupled to the reaction vessel 33 to facilitate control of thermal cycling therein. The device may optionally include a coupling fixture 819 for mounting the device on a tube. In some embodiments, the device may be secured to a fixture that positions the device adjacent to the tube. An opposing reference surface 811b of the first TEC thermally engages an active surface 812a of the second TEC 812 through a thermal capacitor layer. This configuration may also be described as the reference surface 811b being in direct thermal contact with one side of the thermal capacitor layer 813 and the active surface 812a being in direct thermal contact with the other side of the thermal capacitor layer 813. In some embodiments, the reference surface 812b of the second TEC is thermally coupled to a heat sink 817 and / or a cooling fan 818, as shown in the embodiment of Figure 33B. In this embodiment, the thermal controller 800 is configured to be thermally coupled along one side of the flat portion of the reaction vessel 33 to allow optical excitation with an optical excitation means 910, such as a laser, from another direction (e.g., the side of the tube) and optical detection with an optical detection means 920 from another direction (e.g., the opposite side of the tube).
[0177] The first TEC 811 includes a thermocouple 816 on or near the active surface 811a to allow for precise control of the reactor temperature. The temperature output of this thermocouple is used in a primary control loop 814 that controls heating and cooling using the active surface 11a. A second thermocouple 816' is included in or near the thermal capacitor layer, and the associated temperature output is used in a second control loop 814' that controls heating and cooling on the active surface 812a of the second TEC. In one embodiment, the first control loop is faster than the second control loop (e.g., the second control loop lags the first), which accounts for the thermal energy transferred and stored in the thermal capacitor layer. Using these two control loops, the temperature difference between the active surface 811a and the reference surface 811b of the first TEC 811 is controlled to optimize and improve the efficiency of the first TEC. This allows for faster and more stable heating and cooling in the first TEC. Thermal capacitors, on the other hand, allow for much faster switching between heating and cooling, as described herein and shown in the experimental results below.
[0178] Instead of gluing a standard heat sink to the ceramic plate facing the reaction vessel, a separate (secondary) TEC is used to maintain the temperature within about 40°C of the active surface of the main TEC. In some embodiments, two PID (proportional integral derivative) control loops are used to maintain this operation. In some embodiments, a non-PID control loop is used to maintain the temperature of the active surface of the main TEC. Typically, a fast PID control loop drives the main TEC towards a pre-determined temperature set point and is monitored by a thermistor attached to the underside of the ceramic plate in contact with the reaction vessel. This loop runs at maximum speed to ensure the controlled temperature is reached quickly and accurately. In some embodiments, a second, slower PID control maintains the temperature to the bottom surface of the main TEC to maximize thermal efficiency (determined experimentally to within 40°C of the active surface temperature). As mentioned above, a non-PID control loop can also be used to maintain the TEC temperature to maximize thermal efficiency. In some embodiments, it is also advantageous to reduce the interaction between the two control loops to eliminate one loop controlling the other. Additionally, it may be advantageous to use a thermal capacitor layer to absorb and store thermal energy from the first and / or second TECs to facilitate rapid switching between heating and cooling.
[0179] Two non-limiting exemplary methods for achieving rapid and efficient switching between heating and cooling are detailed herein for use in some embodiments of the present invention. First, the bandwidth response for the secondary control loop is intentionally limited to be much slower than the fast primary loop. This is the so-called "delay loop." Second, a thermal capacitor is sandwiched between the two TECs. While it is desirable for the overall thermal control device to be relatively thin to allow for use of the device in the reaction chamber portion of the reaction vessel, it is understood that the thermal capacitor layer can be a little thicker as long as it provides sufficient mass and conductivity to act as a thermal capacitor for both TECs. In some embodiments, the thermal capacitor layer is a thin copper plate, approximately 1 mm thick or less. Copper is advantageous because of its extremely high thermal conductivity, and a thickness of 1 mm was experimentally determined to adequately suppress the two TECs while providing enough mass for the thin layer to store thermal energy to act as a thermal capacitor. Copper is particularly useful due to its thermal conductivity and high mass, but it will be appreciated that various other metals or materials with similar thermal conductivity properties and high mass can also be used, preferably materials with thermal conductivity (even if less than either TEC) and mass equal to or greater than either TEC, allowing the layer to act as a thermal capacitor in storing thermal energy. In another embodiment, the thermal capacitor layer may include a second thermistor used to monitor the "backside" (e.g., reference surface) temperature for use in the secondary PID control loop. Both control loops can be digitally implemented in a single PSoC chip (Programmable System on a Chip) that sends control signals to two bipolar Peltier current sources. Those skilled in the art will appreciate that in some embodiments, non-PSOC chips can also be used for control, such as field programmable gate arrays (FPGAs), which are also suitable for use with the present invention. In some embodiments, the dual TEC module includes a heat sink to prevent thermal runaway. This can be glued to the backside of the secondary TEC, for example, using thermally conductive silver epoxy. Alternative adhesive methods and materials suitable for use in the present invention will be familiar to those skilled in the art.
[0180] Figure 33B is a schematic diagram of the dual TEC design. The temperature of the PCR reaction vessel (measured by a thermistor (16) (oval)) is managed by the primary TEC and controlled by a loop in the PSoC firmware. Optimal thermal efficiency of the primary TEC is maintained by a second thermistor (816') (oval) in thermal contact with the copper layer. This sends a signal into the secondary PSoC loop that controls the second TEC.
[0181] VIII.C.2.b. Initial dual TEC construction
[0182] FIG. 33C shows an example of a dual TEC heating / cooling module with a thermal control device 800 thermally coupled to one major surface of the reaction vessel, an optical excitation block adjacent to the minor surface of the reaction vessel, and an optical detection block 920 for the opposing major surface of the reaction vessel 33. In some embodiments, the main and secondary TECs (Laird OptoTEC HOT20,65,F2A,1312, data sheet below) are 13 (width) x 13 (length) x 2.2 (thickness) mm in size and have a maximum thermal efficiency of 60%. In some embodiments, the flats affected by the TEC modules are sized to fit a GX reaction vessel. In some embodiments, they are configured to accommodate reaction vessels in the range of 25 μl to 100 μl.
[0183] FIG. 33B shows an exemplary dual TEC module for single-sided heating and cooling of a reaction vessel in a chemical analysis system. It will be appreciated that this design may be modified in some embodiments to provide dual TECs on both sides for double-sided heating. As can be seen, the heat sink includes a mini-fan to drive off heat and maintain TEC efficiency. The main TEC (top) cycles the temperature in the reaction vessel and is monitored by a thermistor attached to the underside of the ceramic that contacts the tube. The "backside" TEC maintains the temperature of the sandwiched copper layer (with the aid of a thermistor) to ensure optimal thermal efficiency of the main TEC. The heat sink, integrated with a mini-fan, keeps the entire module in thermal equilibrium.
[0184] In some embodiments, a small thermistor with a temperature tolerance of ±0.1°C is glued with silver epoxy to the underside of the top surface of the main TEC. This thermistor senses the temperature applied to the reactor and serves as an input to the PSoC's main control loop, which controls the drive current to the main TEC. The bottom surface of the main TEC is glued with silver epoxy to a 1 mm thick copper plate. The copper plate has a slot into which a second TR136-170 thermistor is embedded with silver epoxy to monitor the "backside temperature". This serves as a signal input to the PSoC's secondary control loop. The secondary TEC, controlled by the secondary control loop, is then sandwiched between the copper plate and an aluminum heat sink. The heat sink is machined to an overall thickness of 6.5 mm, keeping the entire package less than 13 mm thick. The planar dimensions are 40.0 (length) x 12.5 (width) mm, as dictated by space constraints within the compact device. A 12x12mm Sunon Mighty Mini Fan (datasheet below) is glued into an insert machined into the heatsink where the TEC interacts with the heatsink. Note that the mini fan does not need to cool the heatsink directly; a quiet, durable, inexpensive, low voltage (3.3V max) brushless motor is sufficient to maintain heatsink performance by using shear flow to remove hot surface air from the aluminum / air interface, as opposed to direct air cooling (as in some conventional analytical instruments).
[0185] Testing of the prototype unit will determine whether the heating / cooling rates, thermal stability, robustness to high ambient temperatures, and overall system reliability are sufficient to meet engineering requirements. Thermal performance was shown to be acceptable to achieve the design goals for an exemplary compact system: smaller, more robust, and less expensive (fewer parts than dual-sided heating / cooling). Additionally, single-sided heating / cooling allows for more efficient optical detection through the side of the reaction vessel.
[0186] Figure 33C shows a CAD drawing of the reaction vessel with dual TEC heating / cooling modules and LED excitation and detection blocks in an exemplary system. The reaction vessel is thermal cycled on one side (first major side of the reaction vessel) and fluorescence detection occurs through the other side (second major side of the reaction vessel). LED illumination through the end (minor side) of the reaction vessel remains intact.
[0187] VIII.C.2.c. Initial heating / cooling performance
[0188] The heating and cooling performance of the exemplary TEC assembly was measured using a custom fixture that clamped the TEC assembly to one side of the reaction vessel. Care was taken to thermally isolate the TEC assembly from the fixture by making the fixture out of thermally insulating Delrin. To mimic the heat load of PCR, the reaction vessel was filled with a fluid sample that was in firm contact with a fluorescent detection block on the opposite tube side of the TEC assembly. Note that the temperature of the top surface of the TEC that contacts the tube in this configuration was measured independently to be equal to or greater than the temperature measured on the primary TEC thermistor. It is therefore reasonable to first characterize the thermal performance of the dual TEC heating / cooling system with the temperature reading of the primary TEC thermistor. Any discrepancy between the thermistor and reaction vessel temperature can be accounted for and adjusted for using a feedback loop between the primary TEC thermistor and the fluid sample temperature in the reaction vessel.
[0189] In some embodiments, a thermal control device is secured to the reaction vessel with a clamping fixture for thermal characterization. In one example, the reaction vessel can be filled with a fluid sample and secured in thermal contact with a heating / cooling module on one side of the reaction vessel. The other side of the tube can be clamped to a fluorescence detection block. An LED excitation block illuminates the solution through the end of the tube. In some embodiments, both excitation and detection are performed through the other side of the tube.
[0190] In some embodiments, the PSoC control board utilizes PID control to maintain the temperature setting of the main TEC thermistor, provide bipolar drive current (positive voltage for heating, negative voltage for cooling) to the TEC device, and power the mini fan. This PID loop was tuned to maximize the main TEC performance. A script was written to cycle the tube set points between the high and low limits characteristic of PCR thermal cycling. Specifically, a low set point = 50°C with a dwell time of 12 seconds and start when the measured temperature is ±0.1°C for 1 second. Similarly, a high set point = 95°C for 12 seconds with the set point held at ±0.1°C for 1 second. The script cycles between 50°C and 95°C indefinitely.
[0191] A secondary control loop is also kept in the same PSoC, reading the temperature of a secondary thermistor in thermal contact with the copper suppression / thermal capacitor layer (see Figure 33A) and acting on the secondary TEC. A different set of PID tuning parameters was found to adequately maintain the thermal performance of the system by controlling the temperature of this copper layer, the so-called "backside" temperature. This control loop, as expected, has a much lower bandwidth than the primary control loop. The PSoC and associated programs also allow multiple set points for the backside temperature, which is useful for maximizing ramp rate performance by keeping the primary TEC operating under the most efficient thermal conditions.
[0192] FIG. 34 shows an example thermal cycle from the reactor temperature, where the traces were measured for a thermal cycle of 50°C→95°C→50°C under closed loop control (main trace). The closed loop heating and cooling rates are ∼7°C / sec. The control primary is the desired temperature set point of the thermal cycle (a rectangular function between 0 and 20 seconds of elapsed time) and the primary trace is the measured tube temperature. As can be seen, the actual thermal cycle lags behind the desired thermal cycle indicated by the control primary function. The thermal efficiency of the main TEC was found to be highest when the temperature differential between the tube and the backside was 30°C or less. Thus, the backside temperature was controlled to be 65°C when heating to the maximum temperature (tube 95°C) and 45°C when cooling the tube to 50°C (backside trace). Once the main TEC is ramped up to a high temperature, it is possible to slowly and controllably drive the backside temperature to a low temperature in anticipation of the next thermal cycle, shown to begin at approximately 37 seconds in elapsed time. This approach is similar to using the backside TEC to appropriately apply a "thermal spring" acting on the main TEC and is applicable for use in PCR since the thermal profile to be applied to a particular PCR assay is known a priori by the assay designer. Note that the stable and repeatable closed-loop temperature ramp rates for heating and cooling are ∼6.5 seconds for a 45°C span as shown for 10 consecutive thermal cycles in Figure 35, corresponding to a true closed-loop temperature ramp rate of ∼7°C / sec for both heating and cooling. Performance is maintained over the full range of PCR thermal cycles and through multiple cycles.
[0193] VIII.C.2.d. Early and near-term reliability testing
[0194] A typical PCR assay has approximately 40 thermal cycles from the annealing temperature (~65°C) to the DNA denaturation temperature (~95°C) and back to the annealing temperature. For reliability evaluation, an exemplary thermal control module was cycled between 50°C (which is the lowest temperature level used in PCR experiments) and 95°C, with a 10 second wait time at each temperature to allow for thermal equilibration of the system.
[0195] Figure 36A shows a comparison of the first 5 cycles and the last 5 cycles of a 5,000 cycle test. Note that the time axis in the right trace is from a small data sampling range. The 5,000 cycles take approximately 2 days. This module has since been cycled over 10,000 times and performance was maintained. As can be seen, the thermal cycle performance for cycles 1-5 (left) remains constant after 5,000 cycles (cycles 4,995-5,000 on the right), and there is no difference in thermal performance between the first and last cycles. This is promising for two reasons. First, the closed loop parameters for rapid heating / cooling are very stable with repeated thermal cycling. Even small thermal instabilities would result in drift in the measured temperature curves for both the main and backside TECs, quickly escalating to thermal runaway (thereby causing overcurrent shutdown failures in the firmware). A properly tuned system would not exhibit this behavior, demonstrating the robustness of the system. Second, the thermal efficiency of the module is stable for over 5,000 cycles. In fact, this unit has been subsequently cycled over 10,000 times without any catastrophic or gradual degradation in performance. Figure 36B shows the thermal cycling performance for the first five cycles and after two days of continuous thermal cycling.
[0196] VIII.D. Thermal Modeling Techniques for Heat Cycle Control
[0197] In another aspect, the thermal control device can be configured to control temperature based on thermal modeling. This aspect can be used for thermal control devices configured for single-sided or double-sided heating. In some embodiments, such devices include a first thermoelectric cooler and another thermal manipulation device, each coupled to a controller that controls the first thermoelectric cooler in conjunction with the thermal manipulation device to improve the control, speed and efficiency of heating and / or cooling at the first thermoelectric cooler. However, it is understood that this thermal modeling aspect can be incorporated into the control of any of the configurations described herein.
[0198] An example of such an approach is shown in the state model diagram in Figure 37. This diagram shows a seven state model for use in a single-sided thermal control device. The model applies electrical theory to model the temperatures of a real-world thermal system, including the temperatures of the thermoelectric cooler surface, the reaction vessel or vessel, and the fluid sample within the reaction vessel. The diagram shows the seven states of the model and the three measurement states used in the Kalman algorithm to arrive at an optimal estimate of the reaction vessel contents, assumed to be water.
[0199] In the circuit model of FIG. 37, the capacitors represent the heat capacity of the material, the resistors represent the thermal conductivity of the material, the voltages of the capacitors and power supplies represent the temperature, and the current sources represent the heat input from the front side thermoelectric cooler (TEC) adjacent to the tube face. In this embodiment, the inputs to the model are the back side TEC temperature, which can be predicted by the models T1-T7, the heat input (watts) of the front side thermoelectric cooler, and the temperature of the opposing container or "block" adjacent to the tube face. This is all of the model part of the algorithm. As mentioned above, the Kalman algorithm generally uses the model with the measured sensor signals, which are also part of the model output. Here, the thermistor measurement signal, converted to temperature, is used for the front thermoelectric cooler and also for the back side thermoelectric cooler. Although the measured temperature on the back side is not an output of the model, it is assumed to be the same. One reason for this assumption is that R1 is negligible in terms of the overall thermal conductance.
[0200] VIII.C.2.e. Alternative TEC designs
[0201] Variability in module construction can lead to slight differences in device performance. For example, current modules are hand assembled with machined heat sinks and sandwiched copper layers. All components are then hand bonded together using conductive epoxy. Variations in epoxy thickness or small angles between components within the sandwich structure of the module will lead to differences in thermal performance. Most importantly, the thermistor is also attached to the ceramic with thermal epoxy. Any small air gap between the thermistor and ceramic will lead to errors between the controlled and measured temperatures. Finally, soldering small wires to make electrical connections for the two TECs, two thermistors, and the power leads of the fan is very time consuming.
[0202] In some embodiments, a thermal device (e.g., a TEC apparatus as described herein) has a heating and cooling surface on each major surface (opposite sides) of a reaction vessel. In such embodiments, optical detection may be performed along a minor surface (e.g., an edge). In some embodiments, optical detection is performed along a first minor surface and optical excitation is performed along a second minor surface that is orthogonal to the first minor surface. Such embodiments may be particularly useful when heating and cooling of larger volumes (100-500 μl of fluid sample) is required.
[0203] In some embodiments, the thermal controller module uses a custom Peltier device that includes an integrated surface mount thermistor attached to the underside of a ceramic plate in contact with the reaction vessel. Using a tiny 0201 package thermistor (0.60 (length) x 0.30 (width) x 0.23 (thickness) mm) limits component thickness, miniaturizing convection currents inside the Peltier device that lead to temperature variations. Additionally, precise control of the thermal contact and position of the surface mount thermistor allows these components to have an extremely stable and characterizable difference between measured and actual ceramic temperature.
[0204] In some embodiments, the thermal control device can include a custom Peltier designed to be fully integrated into the heating / cooling module using semiconductor mass production techniques ("pick and place" machines and reflow soldering). The sandwiched copper board can be replaced with a Bergquist thermal interface PC board (1 mm thick copper board) with precisely controlled copper thickness and pad dimensions. The Bergquist board can also provide pad leads for the backside thermistor and all electrical connections in and out of the module. The backside Peltier can remain a similar device to the one currently used. Finally, the entire TEC assembly can be encapsulated with silicone to make it water resistant. In some embodiments, the aluminum mounting bracket can also double as a heat sink.
[0205] IX. Diagnostic Platform
[0206] Figure 38 is a simplified block diagram showing a schematic configuration of a diagnostic assay system, according to some embodiments of the present invention. As with all figures herein, various embodiments may vary from the illustrated example. For example, in some embodiments, the components shown in Figure 38 may be combined, separated, added, and / or omitted. Furthermore, the functionality of each of the components may be provided by one or more devices (e.g., computing devices) located in one or more locations.
[0207] Although the drawings may refer to "Epsilon devices," "Epsilon handheld platforms," and certain remote services, various embodiments within the scope of the present invention are not so limited. The techniques described herein are described more generally and may be utilized by any medical device, mobile or other computing device, and remote server. Additionally, certain software components and functions described herein may be replaced with various types of similarly functional software. Those skilled in the art will recognize several variations to the embodiments shown herein and described below.
[0208] As shown in FIG. 38, a diagnostic assay system can generally include three types of components: a diagnostic device ("Epsilon Instrument Hardware", also referred to herein and in the drawings as an "instrument" or "diagnostic device module" or "diagnostic device"), a mobile device ("Epsilon Handheld Platform"), and a remote service (collectively exemplified "Remote Xpert System" and "Remote Xpert+ System"). A more detailed description of these components is provided below. The diagnostic device and mobile device can be co-located at the point of care, such as a clinic, hospital, or other facility, and the remote service can be located at one or more remote locations. Depending on the desired functionality and as indicated above, embodiments can use multiple diagnostic devices, mobile devices, and / or remote services.
[0209] The diagnostic device shown in FIG. 38 includes the illustrated Epsilon instrument hardware and various software components shown therein, including Epsilon instrument core software, Epsilon Xpert software, Epsilon instrument interface software, and distributable assays. These components can communicate with each other using various interfaces and application programming interfaces (APIs) as shown. As previously described, the diagnostic device can include a diagnostic assay system having a testing component and a computing component configured to perform diagnostic assays and provide resulting data to a remote service via a mobile device. In some embodiments, the diagnostic device can further process and / or store assay data from one or more assay results. The components can be implemented, at least in part, using a combination of software and hardware, which can be incorporated into a computer system (such as described in connection with FIG. 53).
[0210] In some embodiments, the diagnostic device allows hand-off processing of patient samples and can provide both summary and detailed test result data to a remote service. Interface software (shown as "Epsilon Instrument Interface Software") allows the diagnostic device to communicate with mobile device software (shown as "Epsilon Handheld Software") running on a mobile device. Communication may be wireless using any of a variety of wireless technologies, such as Near Field Communication (NFC), Bluetooth, Wi-Fi, etc.
[0211] By establishing this communication with the mobile device, the interface software allows a user of the mobile device to control various functions of the diagnostic device. For example, using a graphical user interface on the display of the mobile device, the user may manage device settings of the diagnostic device; start, pause, cancel tests performed by the diagnostic device; identify remote services to transmit data from the diagnostic device; identify the type, content, and / or format of data; etc. According to some embodiments, the mobile device may also allow the user to access medical and / or other data stored in the diagnostic device. However, according to some embodiments, the accessed data may not be stored on the mobile device, so that the security of the data is not compromised in the event of loss or theft of the mobile device. This functionality has the advantage of helping the system comply with and comply with various privacy laws, regulations, and other standards.
[0212] The level of control provided to a user by the interface software via a mobile device may depend on the level of authorization given by the user and / or mobile device. A user with a higher authorization level, for example, may be able to access features of the diagnostic device to which a user with a lower authorization level does not have access. The interface software may provide authorization and / or authentication of the user and / or mobile device prior to and / or during communication, for example, by requesting login information or similar unique data that helps ensure system security.
[0213] The diagnostic device can communicate with multiple mobile devices, and can do so simultaneously (or substantially simultaneously), thereby allowing multiple users to control the diagnostic device. To that end, the interface software can provide authorization and / or authentication to each of the multiple mobile devices. In some embodiments, when the diagnostic device is actively communicating with multiple mobile devices, one of the mobile devices can be designated as a primary mobile device through which all data is sent to the remote service. That is, in some embodiments, the diagnostic device can be controlled by multiple mobile devices, but the diagnostic device is tethered to one primary mobile device through which the diagnostic device sends data to the remote service.
[0214] Mobile devices can include mobile electronic devices such as smartphones, tablet computers, laptops, and the like. The software for the mobile device can be executed as an application on the mobile device and can be agnostic to the operating system (OS) of the mobile device. As such, any of a wide range of mobile devices can function as a mobile device as described in the embodiments herein, once the mobile device software is installed on the mobile device and appropriate authentication is performed. As shown in FIG. 38, the mobile device can also be connected to a printer device, such as an off-the-shelf thermal printer.
[0215] In some embodiments, the mobile device software may enable authorization and / or authentication of multiple diagnostic devices and the mobile device, such that one user may control multiple diagnostic devices at once with one mobile device. In addition to controlling the diagnostic devices via the mobile device software, the mobile device may also enable the diagnostic devices to communicate with (e.g., provide data to) a remote service via a tethering feature, allowing data communicated from the diagnostic device to the mobile device (e.g., via NFC, Bluetooth, Wi-Fi, etc.) to be relayed to the remote service using the mobile device's connection to a wide area network (WAN), which may utilize cellular (e.g., third generation (3G), long term evolution (LTE), etc.), satellite, and / or other wireless technologies.
[0216] More generally, the techniques described herein can provide a diagnostic assay system in which one or more diagnostic assays can be controlled on a peer basis by a mobile device using local area network (LAN) based functionality. The same protocols can be used on the mobile device for individual WAN communications to remote services. Thus, the mobile device can be an independent router for this latter functionality. While the embodiments described herein describe the use of mobile or "handheld" devices, other embodiments can utilize computing systems that may not be considered mobile or handheld, such as personal computers. Features of mobile devices and other computing devices described herein are described in more detail below with reference to FIG. 53.
[0217] In some embodiments, the tethering functionality can provide a connection between the diagnostic device and the remote service without persistent data storage on the mobile device. In other words, the mobile device may have no knowledge of the data being transferred. In some embodiments, for example, the mobile device may receive sensitive encoded data, e.g., patient data, from the diagnostic device, which is simply transmitted to the remote reporting system without storage or decoding on the mobile device. In such embodiments, the security of the data is therefore not compromised even if the mobile device is lost or stolen. This adds another layer of privacy protection to the system and can help the system comply with privacy laws, regulations and other standards. Furthermore, the functionality of the diagnostic assay system can be relatively simply restored by simply replacing a lost or stolen mobile device. Such functionality allows the technology described herein to be utilized not only in laboratories, but also in off-site locations (e.g., Ebola clinics in remote areas of Africa) where mobile devices are more susceptible to loss or theft.
[0218] Referring again to FIG. 38, the remote service can be run in the "cloud" by one or more servers, which may be in one or more locations remote from the mobile device and / or diagnostic devices. The remote service can collect data from one or more diagnostic devices, synthesize the data, and store the data in a database. The remote service can not only collect data from one or more diagnostic devices in one location (e.g., communicating via a particular mobile device), but can also aggregate information broadly from diagnostic devices in different facilities in different geographic locations, thereby providing large-scale epidemiological data and determining other valuable health and disease information in one or more populations.
[0219] Additionally or alternatively, the remote service may collect and process data and provide a secure portal (e.g., accessible via the Internet) to a viewer (e.g., a government agency) through which the processed data may be accessed in various formats (e.g., lists, graphs, maps, etc.) depending on the viewer's authorization level, where data transmitted to the remote service for processing is encrypted (or otherwise securely transferred) and / or handled in a manner that complies with laws, regulations, standards, and / or other applicable administrative requirements.
[0220] It will be appreciated that the components illustrated in Figure 38 can communicate with each other directly using the aforementioned wireless technologies or as part of one or more larger data communications networks, such as the LANs and / or WANs described in the embodiments above. The data communications networks can include any combination of various data communications systems, such as, for example, cable, satellite, wireless / cellular, or Internet systems, utilizing various technologies and / or protocols, such as radio frequency (RF), optical, satellite, coaxial cable, Ethernet, cellular, twisted pair, other wired and wireless technologies, etc. The data communications networks can include packet-based and / or circuit-based switching, and can include open, closed, public, and / or private communications networks, including the Internet, depending on desired functionality, cost, security, and other factors.
[0221] The following description and figures illustrate embodiments of various aspects of the diagnostic assay system shown in FIG. 38. Although specific hardware and software components are described with respect to the disclosed embodiments, those skilled in the art will appreciate that in some embodiments, certain of such components may be substituted, replaced, omitted, and / or otherwise modified as compared to other embodiments. For example, a Programmable System on a Chip (PSoC) may be replaced with multiple parts providing substantially the same functionality. Those skilled in the art will be familiar with a variety of mixed signal and / or analog microcontrollers suitable for use with the present invention. The Representation State Transfer (RST) interface may be replaced and / or used in conjunction with other software structures and / or protocols, such as Create-Read-Update-Delete (CRUD), Domain Application Protocol (DAP), Hypermedia as Application State Engine (HATEOAS), Open Data Protocol (OData), RESTful API Modeling Language (RAML), RESTful Services Description Language (RSDL), etc., where appropriate.
[0222] IX.B.Epsilon Device Core Software
[0223] As shown in FIG. 38, in some embodiments, the Epsilon instrument core software (also referred to as diagnostic assay system software) can include various software modules. Suitable modules that can be included in the instrument core software can include a Cellcore operating system module, a hardware state machine module (HSM), an iCORE software module, a valve software module, a syringe / door software module, and / or an ultrasound horn software module. In some embodiments, the Cellcore operating system module is a version of Linux and support services that run on the Cellcore processor. In some embodiments, the HSM module can include all diagnostic device specific software that runs on the Cellcore processor and outside of the Java Virtual Machine (JVM). In some embodiments, the iCore software module includes all software that runs on the iCore PSoC. In some embodiments, the valve software module includes all software that runs on the valve PSoC. In some embodiments, the syringe / door software module includes all software that runs on the syringe / door PSoC. In some embodiments, the horn software module includes all software that runs on the horn PSoC.
[0224] In some embodiments, the Epsilon instrument interface software can include an Epsilon Instrument REST Interface module and an Epsilon Assay Runner software module.
[0225] In some embodiments, the Epsilon Xpert Reporter software acts as a client to the remote Xpert software and runs on the Cellcore processor of the Epsilon instrument hardware in the same JVM as the Epsilon instrument interface software.
[0226] The Epsilon instrument hardware can be the physical subsystem that performs the assays, in some embodiments, this subsystem includes only the instrument hardware, and the software running on the instrument operates as a separate subsystem.
[0227] IX.C. Mobile Devices
[0228] As shown in Figure 38, in some embodiments, the mobile device can include various software modules. For example, the illustrated Epsilon handheld software can comprise an Android application executed by a mobile device specifically designed to support the system shown in Figure 38 when deployed in a field context. In some embodiments, applications for other operating systems can be utilized. In some embodiments, the software can include all of the necessary functionality to support patient testing in the diagnostic device field of application and / or functionality to facilitate Cepheid service departments (or the service department of another provider) remotely supporting these devices.
[0229] In some embodiments, the mobile device may comprise an off-the-shelf Android handheld target platform selected to support the field context.
[0230] IX.D. Remote Xpert+ System
[0231] In some embodiments, the Remote Xpert+ system shown in FIG. 38 can include a set of web applications exposed as services for use by the Remote Xpert system and Epsilon handheld software. REST and / or similar services (as described above) can be used for internal communication within the Remote Xpert+. In some embodiments, a limited number of services of the Remote Xpert+ system can be exposed to external systems, such as the Remote Xpert and Epsilon handheld software. According to some embodiments, the primary role of the Remote Xpert+ can be to enable centralized management of users, facilities, commands, and kits.
[0232] IX.E. Remote Xpert System
[0233] According to some embodiments, the Remote Xpert system, as shown in Figure 38, can include a set of web applications that facilities use to manage their equipment and clinical data. Such facilities can include, for example, national or international organizations (e.g., the World Health Organization), emergency response organizations, universities, hospitals, etc. In some embodiments, the Remote Xpert software can further include analysis software that analyzes the received and / or transmitted data.
[0234] IX.F. Dispersible Assays
[0235] In some embodiments, components of the embodiment of the distributable assay of the diagnostic device shown in FIG. 38 may include an assay header (summary information for assay management), an assay definition (which may be, for example, a receiving file), and / or assay UI tailoring (defining an assay-specific UI, such as special sample preparation presentation instructions). Such tailoring may be limited to areas specified in the UI design, such as sample preparation steps and / or assay-specific help screens. In some embodiments, the distributable assay may optionally include assay-specific software to allow for the incorporation of new algorithms required for future assays. This may require that the software running the assay supports this type of extension. Furthermore, in some embodiments, the distributable assay may include localized handheld assay resources as required. This may include various resources used to implement the UI for a particular assay. Examples include localized symbol strings for supported languages, new graphic resources such as icons, if any, and / or required help files (e.g., portable document format (PDF) of the insert or training videos). It should further be noted that in some embodiments, localized resources may need to be split into "assay language packs" or kits due to size constraints (e.g., localized training videos) and regional differences.
[0236] IX.G. External Interfaces - Diagnostic Equipment
[0237] In some embodiments, the diagnostic device shown in FIG. 38 can include one or more external interfaces. For example, the Epsilon handheld application GUI can be a user interface on a mobile device that also serves as the diagnostic device's user interface. The Remote Xpert GUI can be a web-based user interface provided by the Remote Xpert. The Remote Xpert+ GUI can be a web-based user interface provided by the Remote Xpert+. In some embodiments, this GUI can be accessible only by the entity that provides and / or maintains the Remote Xpert+. Additionally or alternatively, the external interface can include SMS messaging that can be used to report results to a public clearinghouse, or can be provided by the carrier via the operating system of the mobile device. The diagnostic device can include a data streaming interface (GX Streaming Data Interface shown in FIG. 38) that allows a personal computer or other computing device to provide visualization of data that can aid in development and debugging. Thus, this interface may not be used when deployed to a site in some embodiments.
[0238] IX.H. Internal Interfaces - Diagnostic Equipment
[0239] In some embodiments, the diagnostic device shown in FIG. 38 may include one or more internal interfaces. For example, an Epsilon instrument hardware / software interface may comprise an interface between the instrument hardware and the Epsilon instrument core software. A GXIP+ interface may comprise an interface provided by the Epsilon instrument core software and used by specific software in both clinical setting and site use contexts. An assay runner interface may be provided by the Epsilon instrument interface software and may be used with the Epsilon assay runner software or similar assay software. An instrument persistence API may comprise an interface provided by the Epsilon instrument interface software and used by the Epsilon Xpert reporter software.
[0240] IX.I. Mobile Device Interface
[0241] In some embodiments, the mobile device can include various interfaces. For example, the Epsilon device service interface can comprise the primary interface provided by the Epsilon device interface software. For a site usage context, it can be the interface used by the Epsilon handheld software to perform checks, update device status, and perform other normal operations.
[0242] The thermal printer interface may include an interface provided by an optional thermal printer, which may be an off-the-shelf model with Wi-Fi connectivity. This may allow the Epsilon handheld software to print test results on the printer automatically, or at the user's request after the test results are available. In some embodiments, printers that utilize other technologies (e.g., ink, inkjet, etc.) may be used.
[0243] The Android Platform API may comprise interfaces provided by the Android operating system used to access mobile device hardware and network services. As previously noted, alternative embodiments may include equivalent or similar components for alternative operating systems.
[0244] The coordination interface shown in the embodiment of FIG. 38 provides coordination between mobile devices when multiple mobile devices are active at the same time at a particular location, which may occur when more than one user is working at a busy site or when a spare mobile is active. The coordination interface can be implemented to cross-connect all modules to the user interface functional control layer on the mobile device. The purpose and function is to allow multiple instruments to be controlled and monitored via the mobile device as an autonomous unit, and to allow the operator to coordinate workflow between the devices for proper instrument usage to perform a given diagnosis. Peer-to-peer Wi-Fi managed instruments can have specific control guaranteed per device to maintain continuity of storage and important patient identification parameters. The functionality allows for a ratio of mobile devices to diagnostic instruments of X:Y, where X is any number of mobile devices and Y is any number of diagnostic instruments. In some embodiments, X and Y can be equal in number.
[0245] IX.J. Remote Service Interface
[0246] As shown in Figure 38, the remote services can include various interfaces in some embodiments. For example, the Epsilon Xpert Reporter interface can include a set of REST services that represent the functionality of clinical data upload and / or device synchronization. The Remote Xpert+ Services interface can include a set of REST services that represent the functionality of kit management, user management, institution and site management, remote service commands, and / or device synchronization.
[0247] IX.K. Clinical Laboratory Improvement Amendments (CLIA) - Abandoned Applications
[0248] In some embodiments, the diagnostic device core software interface of FIG. 38 is available in a Clinical Laboratory Improvement Amendments (CLIA)-waived application, where the diagnostic device can provide information via an Ethernet connection to proprietary software running on a personal computer. In alternative embodiments, other computing hardware, software, and / or physical or wireless connections can be used. Additional details regarding the GXIP+ interface are provided below.
[0249] IX.L. Diagnostic Equipment - Software Components
[0250] FIG. 39 illustrates a logical view of the software executed by the diagnostic device according to an embodiment. As shown, the software can include low level drivers including Universal Serial Bus (USB) driver stack, SM bus I / F, Wi-Fi, Bluetooth, and USB dongle drivers. The application layer includes the operating system and other applications. These applications can include a JVM with Xpert Reporter and Epsilon Rest interface components, a JVM with Epsilon Assay Runner components, a Gateway Application with a DX Gateway component, and / or an Epsilon Instrument Core Application with GxIp+, Gx Streaming, PSoC USB, HSM layers, and a Battery I / F and Power Management component.
[0251] 40 is a block diagram of an Epsilon device core architecture according to some embodiments, which illustrates the interaction of various subcomponents of the Epsilon device core architecture, including the NFC interface, GxIp+ interface, HSM.PSoC I / F, Gx Streaming interface, Xpert Reporter / Epsilon REST interface, Epsilon Assay Runner, Dx Gateway, and NB USB, as described herein.
[0252] In some embodiments, the GxIp+ interface may be the main component supporting the GxIp protocol and may implement the necessary Dx business logic. The business logic may be ported from 683xx legacy code as a basis for the "Northbound" instrument interface to ensure compatibility with how assays and commands are executed. In some embodiments, the GxIp+ interface may further include an adaptive layer that connects the "Northbound" legacy GxIp commands with the "Southbound" Epsilon PSoC command interface. In the HBDC context, this may be the Dx equivalent interface used by the Epsilon instrument interface software for assay execution and monitoring.
[0253] In some embodiments, the gateway interface may be a component that supports the GxIp "discovery" protocol. Once discovery is complete, this component acts as a router to remote GxIp-based components and GxIp+ interfaces. In some embodiments, the gateway interface may be a discovery interface on an Epsilon device.
[0254] In some embodiments, the Gx Streaming Interface may be the main component supporting streaming of Epsilon core state vectors to remote clients. During development, this interface can be used to support Engineering Visualization Tools (VTs) to monitor and tune PSoC performance, ultrasonic processing, and fluorometer equivalent monitoring for legacy systems. In some embodiments, the Gx Streaming Interface allows streaming of state swap data to mobile devices.
[0255] FIG. 41 illustrates various states of the HSM component, according to some embodiments. As used in this disclosure, the HSM may include a main component that manages the core device state as well as legacy DX compatible sub-states. Additionally, the HSM may interact with the GxIp component to enable or disable GxIp commands depending on the current device core state. In some embodiments, as shown in FIG. 104, the high-level states may include POST-Power On Self Test, RECOVERY, IDLE, WAITING_FOR_CART, LOADING_CART, CARTRIDGE_LOADED, RUNNING_ASSAY, ABORTING, and CARTRIDGE_PRELOAD. These state names are provided as non-limiting examples, and one of ordinary skill in the art will appreciate that the names and functionality of such states may vary depending on the desired functionality.
[0256] FIG. 42 illustrates the internal components and interfaces of the instrument core according to some embodiments of the present invention. For example, the PSoC USB may be the main component supporting the “Southbound” interface to the PSoC components (Horn, Door, Syringe, Valve, and ICORE). This component may use USB 2.0 to create a “data backplane” between the Cellcore and each PSOC. In some embodiments, at boot-up, the PSoC may enumerate boot-ready endpoints so that new firmware can be programmed onto each PSoC. In some embodiments, during normal operation, the PSoC may be enumerated as an endpoint for commands and an endpoint for state swapping. Here, state swapping may provide high-speed PSoC data virtualization on the Cellcore, allowing monitoring and / or analysis of high-speed PSoC data on the Cellcore, and / or supporting Gx streaming components on the Cellcore.
[0257] In some embodiments, the device PSoC external interface can include a Comms_Task, which can be the primary PSoC supporting the "Southbound" interface between the PSoC and the Cellcore, and which can further be the primary component on the PSoC to form a "data backplane" between the Cellcore and each PSoC. Additionally or alternatively, the Comms_Task can be common to all PSoCs and can create and manage the command and status swapping USB endpoint interface.
[0258] In some embodiments, the analytical tasks may also include another PSoC external interface, which may be the main PSoC component that supports PSoC command processing. In some embodiments, the analytical tasks may include common processing for common commands shared by all PSoCs.
[0259] The device PSoC external interface may further include an ISR, according to some embodiments of the present invention, that allows common processing of time on the PSoC and / or allows specific priority processing to support background trajectories.
[0260] IX.M. Mobile Devices - Software Components
[0261] FIG. 43 is a block diagram illustrating software components executing on a mobile device according to some embodiments of the present invention, where the user interface may follow common Android (or other OS) design patterns. An activity may be a component that controls the flow through the user interface, and the view that is visible at any time. A view may be a set of components that presents information to a user. In some embodiments, most of the business logic may be contained in the service components shown in FIG. 43.
[0262] In some embodiments, the user interface, on a stand-alone module, can present the specific workflow required to perform a cartridge-based diagnostic and ensure accuracy and granularity of patient data related to a particular diagnostic outcome, including automated chain of custody from sample logging via the cartridge to the device database.
[0263] According to some embodiments, the data layer can include a data manager that provides persistence of all databases within the application. In some embodiments, the mobile database is SQLite and can be encrypted using SQLCipher. The mobile database can include authorized users, credentials, and / or log information. Since the mobile device can act as a self-contained mobile router for sending diagnostic data, the data in the database can provide the credentials and authentication for initiating and terminating outgoing connections. Further information for establishing these connections is as follows: In some embodiments, the data layer can further provide two APIs to the rest of the system: a data API for normal database objects and a logging API for logging key events. These APIs connect the mobile diagnostic device to the remote database and transparently move diagnostic data and other descriptive data from the diagnostic device to the contextually correct internet instance of the remote Xpert via the mobile device.
[0264] As shown in Figure 43, an embodiment may include a site manager, which manages the state of the site and may maintain a list of known users, known diagnostic equipment, known mobile devices, known assays, and / or known printers. When the mobile device is connected to the Internet, the site manager may interface with the remote Xpert+ to manage remote service commands to the site. The site manager may also interact with peer mobile devices as needed to manage the state of the site and / or handle user authentication.
[0265] Some embodiments may further include cloud communications, which may provide access to a remote Xpert+ service and / or a configuration manager that manages the current configuration of the mobile device. That is, the cloud communications component may establish and manage a bidirectional communications link with one or more remote services (e.g., a remote Xpert+ as shown in FIG. 38). Communications may be established via one or more APIs that may parse, interpret, and transmit data (e.g., in a proprietary format) into a standard, readable format.
[0266] As further shown in FIG. 43, embodiments may include an equipment manager that manages a list of current equipment (medical diagnostic equipment) and monitors the status of all equipment at the site. The equipment manager may further provide the ability to perform operations on the diagnostic equipment. Such operations may include, for example, running tests using assays, installing assays, installing software upgrades, running diagnostics, and / or synchronizing time references. The equipment manager may also select an equipment when requesting a test and / or handle errors reported by the equipment. According to some embodiments, equipment communication may be encapsulated using the REST API of the medical diagnostic equipment.
[0267] Some embodiments may further include a test manager that can manage a list of operational tests, manage the workflow of test execution, report test results upon completion, and / or "archive" tests when they are no longer operational. In some embodiments, SMS communication may encapsulate reporting of results via SMS to a public clearinghouse. In some embodiments, printer communication may encapsulate the ability to print the report on a local thermal printer.
[0268] In general, the functionality of a mobile device may depend on the available software development kits (SDKs) and APIs for various platforms. For example, with respect to the Android SDK and APIs, application functionality is limited by the public APIs of the Android SDK. Even so, NFC, camera, GPS, SMS messaging, and / or network access may be available using the Android SDK and APIs.
[0269] In some embodiments, the standard databases on Android, SQLite and SQLCipher, may be used. For example, SQLCipher is referenced by the Open Web Application Security Project (OWASP) as the preferred method for securing data on the phone. Nevertheless, alternative embodiments may utilize other platforms, such as iOS, Windows Mobile, etc. Additionally or alternatively, other data structures and / or query languages may be utilized, such as SQL, HTSQL, jOOQ, etc.
[0270] Some embodiments may provide third party remote support applications that allow remote display and, if available, remote control of the mobile device provided by the third party application. In some embodiments, multiple versions of the mobile device software may provide remote control of the application using the associated SDK.
[0271] Among other things, the present invention provides integration on the mobile device with diagnostic equipment control, equipment management, and LAN and WAN connectivity (LAN to WAN routing as mentioned above) that is not used in traditional medical diagnostic industry control and communication. Segmentation of the local control (LAN layer) of the device and communication with each diagnostic equipment can be done on a peer-to-peer level (e.g. over Wi-Fi) and manages the data flow to each equipment, both to the UI control functionality interface and then to the data path interface to the remote Xpert in the cloud.
[0272] The use of NFC on mobile devices can be used to manage chain of custody for patient samples using the NFC adapter shown in Figure 43. Central data provided in the claims allows traceability of these functions and can be stored in a central cloud repository. NFC can simultaneously link the cartridge containing the patient sample to another NFC signal from the diagnostic device to ensure accuracy of storage and reporting requirements are met.
[0273] FIG. 43 further illustrates a communication component of the device that can establish a peer-to-peer Wi-Fi connection between the mobile device and the diagnostic equipment. The communication component of the device allows multiple mobile devices to communicate with each other. In some embodiments, a handheld coordinator can coordinate between multiple mobile devices via Wi-Fi.
[0274] IX.N. Remote Diagnostic Reporting Service - Software Components
[0275] 44 is a block diagram illustrating software components executing in a remote diagnostic reporting service for medical diagnosis and epidemiology according to some embodiments of the present invention. The remote diagnostic reporting service includes, among other things, a web server, an application server, a database server, and a file storage device.
[0276] According to some embodiments, the logical components of the remote diagnostic reporting service shown in FIG. 44 can be described as follows: The remote Xpert+ service can include REST web services used by the mobile device and the remote Xpert. The GUI application can include web applications used by entities that provide services and support to diagnostic assay systems. The private services can include REST web services used by the GUI application. The core business logic services can include REST web services that include all the business logic. The audit and logging services can include REST web services that include all the logging and audit functionality. Finally, the file transfer services can include REST web services that abstract away a file storage solution.
[0277] Among other benefits, the diagnostic reporting service shown in Figure 44 enables automated remote diagnostic reporting from Class 2 or Class 3 medical diagnostic devices to a remote database and presentation layer. Additionally, hierarchical authentication enables real-time remote control for debugging and diagnostics on remote Class 2 or Class 3 medical diagnostic devices over a WAN connection. This can be a service integration of separate functions including real-time diagnostics and time series data to specifically apply to PCR-based diagnostic environments.
[0278] IX.O. Diagnostic Assay System Setup – Workflow
[0279] An example workflow for setting up a molecular diagnostic assay system, such as the system shown in Figure 38, may include the following steps: It will be appreciated that although particular wireless technologies (e.g., GSM, CDMA, Wi-Fi, etc.) are described in the example embodiments below, additional or alternative technologies may be utilized depending on the desired functionality.
[0280] First, a mobile device can be authorized to operate within the diagnostic assay system, where the mobile device utilizes an Internet connection (e.g., cellular connection, Wi-Fi, etc.). For a cellular connection (e.g., GSM, CDMA, etc.), the mobile device may need to be enabled by the carrier. Additionally, the mobile device can be configured via Remote Xpert+, which may entail downloading the user's initial set, determining the approved set of assays, and assigning them to a site.
[0281] Second, a Wi-Fi network can be set up, where one mobile device can be selected to be a Wi-Fi hotspot (e.g., a bridge between LAN and WAN networks) and other mobile devices can connect to the Wi-Fi hotspot. In some embodiments, all diagnostic devices can use one mobile device acting as a Wi-Fi hotspot to directly access the remote Xpert. Additionally or alternatively, one or more additional mobile devices can connect via Wi-Fi to the mobile device acting as the hotspot. If the mobile device acting as the hotspot fails, runs out of power, or is lost, the second mobile device can be used in its place.
[0282] Third, the diagnostic device can be configured. In some embodiments, this process can include sharing Wi-Fi information (e.g., SSID and passphrase) and / or other information with the mobile device. The mobile device can also obtain identifying information from the diagnostic device, such as MAC address, serial number, etc. Sharing of such information can be done using peer-to-peer NFC. Additional diagnostic devices can be added as described above. If physical order is important, the UI of the mobile device can allow the user to specify where to place the new device.
[0283] IX.P. Diagnostic Assay System Data Flow
[0284] Figures 45-46 are data flow diagrams illustrating alternative aspects of a diagnostic assay system, according to some embodiments of the present invention. As with other figures described herein, Figures 45-46 are provided as non-limiting examples. Alternative embodiments may include additional functionality to those shown in the figures, and / or may omit, combine, separate, and / or simultaneously perform the functions shown in the figures. The means for performing the functions of the blocks may include one or more hardware and / or software components, such as those shown in Figures 36 and 53. Those skilled in the art will recognize several variations.
[0285] IX.Q. Diagnostic Assay System Top Level Data Flow
[0286] Figure 45 is a data flow diagram showing the top level data flow in the diagnostic assay system as shown in Figure 38. Here, the components of the diagnostic assay system - the remote service, the mobile device and the diagnostic instrument - are represented as circles and the data flow is represented by arrows.
[0287] The data flow can begin with the mobile device sending a location request (1) to the remote service. This request can be made when the mobile device is at a new site with diagnostic equipment. As shown in Figure 45, this request only needs to be fulfilled once per location.
[0288] The remote service then responds with a location configuration (2), and the remote service and the mobile device exchange configuration descriptions (3). As previously described, this may include downloading the user's initial set from the remote service to the mobile device, determining the authorized set of assays, etc. The remote service may also provide operational updates (4) to the mobile device.
[0289] The mobile device can then enter into a configuration process with the diagnostic device in which the mobile device provides diagnostic device registration (5) and operational updates (6) to the diagnostic device.
[0290] Once configured, the diagnostic device can receive operational instructions from the mobile device. The mobile device can then provide device commands (7) to the diagnostic device, which may be based on user input. As previously mentioned, such commands may include, for example, running a test using an assay, installing an assay, installing a software upgrade, running a diagnostic, and / or synchronizing a time reference. The diagnostic device can provide a command response (8), such as an acknowledgement, a status update, etc.
[0291] If the medical diagnosis is performed by the device command (7), the diagnostic device can then provide an encrypted medical diagnosis result (9) to the remote service. As previously indicated, the mobile device can provide a hotspot through which the diagnostic device may transmit the encrypted medical diagnosis result (9). However, the mobile device cannot decrypt or store the data. Thus, according to some embodiments, the mobile device acts merely as a conduit through which the encrypted medical diagnosis result (9) can be reported to the remote service. In some embodiments, the encrypted medical diagnosis result (10) can be sent to the mobile device for storage. (As previously noted, in some embodiments, the data cannot be stored on the mobile device. In such embodiments, the mobile device can send the data to another device for storage, e.g., storage on a LAN, computer, etc.) Depending on the desired functionality, the encrypted medical diagnosis result (10) sent to the mobile device can be the same as or different from the one sent to the remote service.
[0292] IX.R. Detailed Data Flow for Mobile Devices
[0293] FIG. 46 is a data flow diagram showing the data flow in more detail, with the components of the mobile device - the WAN interface component, the medical diagnostic logic, and the LAN interface component - represented separately.
[0294] Similar to the flow of FIG. 45, the flow shown in FIG. 46 may start with a configuration process between the mobile device and the remote service, where the medical diagnosis logic sends a location configuration request (1.1) to the WAN interface component, which then sends a location configuration request (1.2) to the remote service. The remote service responds by providing a location configuration (2.1) to the WAN interface component, which then provides a location configuration (2.2) to the medical diagnosis logic. Configuration descriptions are then exchanged between the remote service and the WAN interface component (3.1), between the WAN interface component and the medical diagnosis logic (3.2), between the medical diagnosis logic and the LAN interface component (3.3), and between the LAN interface component and the medical diagnosis device (3.4). Operational updates are then passed from the remote service to the WAN interface component (4.1) and from the WAN interface component to the medical diagnosis logic (4.2).
[0295] The diagnostic device configuration can include medical diagnostic device registration (5.1), (5.2) with medical diagnostic logic, LAN interface components and devices. These components also pass operational updates (6.1), (6.2) from the medical diagnostic logic to the diagnostic device.
[0296] Device commands (7.1), (7.2) can then be sent from the medical diagnostic logic to the diagnostic device, and command responses (8.1), (8.2) can be sent back from the diagnostic device to the medical diagnostic logic.
[0297] The encrypted device results (9.1), (9.2) may be sent from the diagnostic device to the LAN interface component and then directly to the WAN interface component without passing through the medical diagnostic logic. The encrypted diagnostic result (9.3) can then be sent to the remote service. As previously discussed, the encrypted diagnostic results (10.1), (10.2) may be sent separately to the medical diagnostic logic. The medical diagnostic logic can then send them to the encrypted diagnostic result storage (10.3). Depending on the desired functionality, this storage may be separate from the mobile device. The encrypted diagnostic results (11.1), (11.2) may also be sent from the medical diagnostic logic via the WAN interface component to the remote service.
[0298] In some embodiments, a remote service may request a diagnosis. As shown in the figure, the remote service requests a diagnosis (12.1), (12.2), (12.3), (12.4), which is relayed to the diagnostic device. This prompts a diagnostic response (13.1), (13.2), (13.3), (13.4), which is relayed back to the remote service.
[0299] IX.S. Diagnostic Assay System Workflow
[0300] Figures 47-52 are flow charts illustrating the functionality of different aspects of a diagnostic assay system, such as that shown in Figure 38, according to some embodiments of the present invention. As with other figures described herein, Figures 47-52 are provided as non-limiting examples. Alternative embodiments may include additional functionality to those shown in the figures, and / or may omit, combine, separate, and / or simultaneously perform the functions shown in the figures. The means for performing the functions of the blocks may include one or more hardware and / or software components, such as those shown in Figures 38 and 53. Those skilled in the art will recognize several variations.
[0301] IX.T. Location Setting Network Flow
[0302] Figure 47 is a data flow diagram illustrating a process for location setting of a diagnostic assay system, according to one embodiment. Means for performing one or more blocks shown in Figure 47 may include a remote service as described herein.
[0303] The process can begin with the mobile device requesting location settings. As previously discussed, examples of data flows for such a request are shown in Figures 45 and 46. If location settings are available, they are provided by the remote service. If not, the remote service returns an error.
[0304] IX.U. Operational Update Network Workflow - Mobile Devices
[0305] 48 is a data flow diagram illustrating a process for providing operational updates to a mobile device in a diagnostic assay system according to some embodiments of the present invention. Means for performing one or more blocks shown in FIG. 48 may include a remote service and / or a mobile device as described herein.
[0306] The process can begin when a locally configured mobile device connects to a remote service. The remote service then obtains a description of the mobile device's operational description. If the description matches the desired mobile device configuration, the process can end there. If not, the remote service sends an operational configuration update to the mobile device.
[0307] IX.V. Operational Update Network Workflow - Diagnostic Devices
[0308] 49 is a data flow diagram illustrating a process for performing operational updates to a diagnostic device in a diagnostic assay system, according to some embodiments. Means for performing one or more blocks shown in FIG. 49 may include a mobile device and / or a diagnostic device as described herein.
[0309] The process can begin when the mobile device obtains a diagnostic device configuration description from a diagnostic device. If the diagnostic device settings are correct, the process can end, otherwise the mobile device can send operational settings updates to the diagnostic device.
[0310] IX.W. Remote diagnostic network workflow
[0311] As discussed above with respect to Figure 46, a remote service can remotely request diagnostic information. Figure 50 is a data flow diagram of such a process in a diagnostic assay system, according to one embodiment. Means for performing one or more blocks shown in Figure 50 can include a remote service, a mobile device, and / or a diagnostic device as described herein.
[0312] The process can begin when a remote service requests diagnostic information. The mobile device receives the diagnostic information request. If the diagnostic request is for the mobile device, the mobile device performs the requested mobile device diagnostics and sends the mobile device diagnostic information to the remote service. Otherwise, the diagnostic request is sent to a diagnostic device identified by the mobile device (which may be one of several at the site and / or communicatively linked to the mobile device). The diagnostic device then performs the requested diagnostics and sends the diagnostic information to the mobile device. Finally, the mobile device sends the diagnostic device diagnostic information to the remote service.
[0313] IX.X. Medical Diagnostic Equipment Command Network Flow
[0314] Figure 51 is a data flow diagram illustrating a process for providing diagnostic device commands in a diagnostic assay system according to some embodiments of the present invention. Means for performing one or more blocks shown in Figure 51 may include a mobile device and / or a diagnostic device as described herein.
[0315] The process can begin with the mobile device sending a command to the diagnostic device, which then processes the received command, and finally, the diagnostic device sends a response to the mobile device.
[0316] IX.Y. Diagnostic Device Registration Network Workflow
[0317] Figure 52 is a data flow diagram illustrating a process for registering a diagnostic device onto a network of a diagnostic assay system according to some embodiments of the present invention. Means for performing one or more blocks shown in Figure 52 may include a mobile device and / or a diagnostic device as described herein.
[0318] The process can begin when the mobile device queries the diagnostic device for the device's physical network identifier, such as a MAC address. The mobile device then provides network access information to the diagnostic device, as previously described herein. Such information can include SSID, username, etc. In some embodiments, communication between the mobile device and the diagnostic device thus far can be via NFC and / or other wireless technologies, as previously described. The diagnostic device then connects to the network, and the mobile device assigns an identifier to the diagnostic device.
[0319] IX.Z. Computer Systems
[0320] Figure 53 is an exemplary illustration of a computer system 5300 that may be incorporated, at least in part, into the devices and components of the diagnostic assay system shown in Figure 38, including the diagnostic device (Epsilon Instrument), mobile device (Epsilon Handheld Platform), and / or remote services (Remote Xpert System and Remote Xpert+ System). Figure 53 is a schematic diagram of a computer system 5300 capable of performing methods provided by various embodiments of the present invention. It should be noted that Figure 53 is intended only to provide a generalized representation of the various components, some or all of which may be utilized as appropriate.
[0321] The computer 5300 is shown to comprise hardware elements that may be electrically coupled (or otherwise suitably communicate) via a bus 5306. The hardware elements may include a processing unit, such as a processor 5310, which may include, but is not limited to, one or more general purpose processors, one or more special purpose processors (digital signal processing chips, graphic acceleration processors, etc.), and / or other processing means, one or more input devices 5315, which may include, but is not limited to, a mouse, a keyboard, a camera, a microphone, a touch screen, medical testing hardware and / or diagnostic components, etc., and one or more output devices 5320, which may include, but is not limited to, a display device, a printer, etc.
[0322] The computer system 5300 may further include (and / or be in communication with) one or more non-transitory storage devices 5325. This non-transitory storage may comprise, but is not limited to, local and / or network accessible storage devices and / or may include disk drives, drive arrays, optical storage devices, random access memory ("RAM"), and / or programmable or flash updatable read-only memory ("ROM"), etc. Such storage devices may be configured to implement any suitable data storage device, including, but not limited to, various file systems, database structures, and the like.
[0323] In some embodiments, the computer system 5300 may include a communication subsystem 5330, which may include, but is not limited to, a modem, a network card (wireless or wired), an infrared communication device, a wireless communication device, and / or a chipset (such as an NFC transceiver, a Bluetooth device, an 802.11 device, a Wi-Fi device, a WiMax device, a cellular communication transceiver, etc.). The communication subsystem 5330 includes one or more input and / or output communication interfaces to enable the exchange of data with a network, other computer systems (e.g., using peer-to-peer communication as described herein), and / or any other electronic device described herein. In some embodiments, the computer system 5300 includes a working memory 5335, which may include a RAM or ROM device as described above.
[0324] The computer system 5300 may comprise software elements, currently shown as being in working memory 5335, including an operating system 5340, device drivers, executable libraries, and / or other code, such as one or more application programs 5345. The application programs may comprise computer programs (e.g., mobile device software, interface software, etc.) provided by various embodiments and / or may be designed to implement methods and / or software architectures as described herein. By way of example only, the methods and / or architectures illustrated in the other figures attached hereto may be implemented as code and / or instructions executable by a computer (and / or a processing unit within a computer). Such code and / or instructions may then be used in one aspect to configure and / or adapt a general-purpose computer (or other device) to perform one or more operations in accordance with the methods described herein.
[0325] A set of these instructions and / or code can be stored on a non-transitory computer readable storage medium, such as storage device 5325 described above. In some embodiments, the storage medium can be incorporated within a computer system, such as computer system 5300. In some embodiments, the storage medium can be separate from the computer system (e.g., a removable medium, such as an optical disk) and / or provided within an installation package, such that the storage medium can be used to program, configure, and / or adapt a general purpose computer with the instructions / code stored thereon. The instructions can be in the form of executable code that can be executed by computer system 5300 and / or in the form of source code and / or installable code that can be compiled and / or installed on computer system 5300 (e.g., using any of a variety of commonly available compilers, installation programs, compression / decompression utilities, etc.) to form executable code.
[0326] It will be apparent to those skilled in the art that substantial modifications may be made according to particular requirements. For example, customized hardware may be used and / or particular elements may be implemented in hardware, software (including portable software such as applets, etc.), or both. Connection to other computing devices, such as network input / output devices, may be used.
[0327] In some embodiments, a computer system (such as computer system 5300) can be used to perform methods according to some embodiments of the invention. In some embodiments, some or all of the steps of such methods are performed on computer system 5300 in response to processor 5310 executing one or more sequences of one or more instructions contained in working memory 5335 (which may be embedded in other code, such as operating system 5340 and / or application program 5345). Such instructions may be read into working memory 5335 from another computer-readable medium, such as one or more storage devices 5325. By way of example only, execution of a sequence of instructions contained in working memory 5335 may cause processor 5310 to perform one or more steps of the methods described herein. Additionally or alternatively, some of the methods described herein may be performed via dedicated hardware.
[0328] As used herein, the terms "machine-readable storage medium" and "computer-readable storage medium" refer to any storage medium that participates in providing data that causes a machine to operate in a specific manner. In some embodiments implemented using computer system 5300, various computer-readable media may be involved in providing instructions / code to processor 5310 for execution and / or may be used to store and / or transport such instructions / code. In some embodiments, computer-readable storage media are physical and / or tangible storage media. Such media may take the form of non-volatile media or volatile media. Non-limiting examples of non-volatile media may include optical and / or magnetic disks, such as storage device 5325. Non-limiting examples of volatile media include, but are not limited to, dynamic memory, such as working memory 5335.
[0329] Non-limiting general forms of physical and / or tangible computer readable storage media may include, for example, a floppy disk, a flexible disk, a hard disk, a magnetic tape, or any other magnetic medium, a CD-ROM, any other optical medium, a RAM, a PROM, an EPROM, a flash EPROM, any other memory chip or cartridge, or any other medium from which a computer can read instructions and / or code.
[0330] Various forms of computer readable media may be involved in carrying one or more sequences of one or more instructions to the processor 5310 for execution. By way of example only, the instructions may initially be carried on a magnetic and / or optical disk of a remote computer. The remote computer may load the instructions into a dynamic memory and transmit the instructions as signals over a transmission medium for receipt and / or execution by the computer system 5300.
[0331] The communications subsystem 5330 (and / or components thereof) typically receives signals, and the bus 5306 can then convey the signals (and / or the data, instructions, etc. carried by the signals) to the working memory 5335, from which the processor 110 retrieves and executes the instructions. The instructions received by the working memory 5335 may optionally be stored in non-transitory storage device 5325 either before or after execution by the processor 5310.
[0332] IX.AA. Process Flow for Diagnostic Assay System Management
[0333] FIG. 54 is a flow diagram 5400 of a method for managing a diagnostic assay system with a mobile device, according to some embodiments of the present invention. As with other figures described herein, FIG. 54 is provided as a non-limiting example. Some embodiments may include additional functionality to those shown in the figure, and / or may omit, combine, separate, and / or perform simultaneously (or closely in time) the functionality shown in one or more blocks of the figure. Means for performing the functionality of the blocks may include a mobile device as described herein, which may implement one or more hardware and / or software components, such as those shown in FIG. 53. Those skilled in the art will recognize several variations suitable for use with the invention disclosed herein.
[0334] At block 5410, the mobile device receives user input to control the functionality of the diagnostic device. As previously described, the mobile device may execute software applications that provide a GUI by which a user may control various functions of the diagnostic device, such as managing device settings of the diagnostic device; starting, pausing, or canceling medical tests performed on the diagnostic device; identifying remote services to which the diagnostic device will transmit data; identifying the type, content, and / or format of the data, etc. At block 5420, in response to receiving the user input, the mobile device transmits control information to the diagnostic device. If the mobile device is communicatively linked to multiple diagnostic devices, the mobile device may first need to select or identify a diagnostic device from the multiple diagnostic devices.
[0335] At block 5430, the mobile device receives data from the diagnostic device. The received data may correspond to the type, content, and / or format of data identified at block 5410 (if such characteristics were identified). However, as previously indicated, the mobile device may act as a mere pass-through device through which the diagnostic device may communicate with a remote server (e.g., one or more remote services as shown in FIG. 101). In other words, the mobile device may act as a transparent bridge connecting a LAN (which may be peer-to-peer connected as described herein) to a WAN. However, as specified at block 5440, the received data may be relayed to the server without storing or decrypting the data, thereby ensuring that sensitive patient data is not compromised by the mobile device.
[0336] The methods, systems, and devices described above are examples. Various configurations may omit, substitute, or add various procedures or components, as appropriate. For example, in alternative configurations, the method may be performed in an order different from that described, and / or various steps may be added, omitted, and / or combined. Also, features described with respect to particular configurations may be combined in various other configurations. Different aspects and elements of the configurations may be combined in a similar manner. Also, technology evolves, and some of the described elements are provided as non-limiting examples and are not intended to limit the scope of the disclosure or claims.
[0337] Specific details have been set forth in the description to provide a thorough understanding of the example configurations (including implementations). However, the configurations may be practiced without these specific details. For example, well-known circuits, processes, algorithms, structures, and techniques have been shown without unnecessary detail to avoid obscuring the configurations. This description provides example configurations, which do not limit the scope, applicability, or configurations of the claims. Rather, the description of the configurations set forth above will provide one of ordinary skill in the art with an enabling description of the described technology. Various changes may be made in the function and arrangement of elements without departing from the spirit and scope of the present disclosure.
[0338] Also, the configurations may be described as a process that is shown as a flow diagram or block diagram. While each operation may be described as a sequential process, some of the operations may be performed in parallel or simultaneously. Furthermore, the example methods may be implemented by hardware, software, firmware, middleware, microcode, hardware description languages, or any combination thereof. If implemented in software, firmware, middleware, or microcode, the program code or code segments to perform the necessary tasks may be stored in a non-transitory computer readable medium, such as a storage medium. A processor may perform the described tasks.
[0339] The terms "and" and "or" as used herein may include various meanings that are expected to depend at least in part on the context in which the term is used. In general, when used in the context of a list such as A, B, or C, "or" is intended to mean A, B, and C, used in an inclusive sense, and A, B, or C, used in an exclusive sense. Furthermore, as used herein, the term "one or more" may be used to describe only one of any feature, structure, or characteristic, or may be used to describe any combination of features, structures, or characteristics. However, it should be noted that this is merely an illustrative example, and claimed subject matter is not limited to this example. Furthermore, the term "at least one" when used in the context of a list such as A, B, or C, may be interpreted to mean any combination of A, B, and / or C, such as A, AB, AA, AAB, AABBCCC, etc.
[0340] Although several example configurations have been described, various modifications, alternative constructions, and equivalents may be used without departing from the spirit of the disclosure. For example, the above elements may be components of a larger system in which other rules may take precedence over or modify the application of the invention. Also, some steps may occur before, during, or after considering the above elements. Thus, the above description does not bind the claims. All patents, patent applications, and other publications cited in this application are incorporated by reference in their entirety for all purposes.
Claims
1. 1. A system for operating a syringe drive for a diagnostic assay system, comprising: a diagnostic assay system chassis; a brushless DC (BLDC) motor coupled to the chassis of the diagnostic assay system, the motor not using any position or pressure sensors and not including any encoder hardware; a back-drivable lead screw operable by the BLDC motor; a plunger rod operable by said lead screw to engage a removable assay cartridge; Equipped with The BLDC motor is configured to operate the lead screw by monitoring a current drawn by the BLDC motor, the current varying in response to pressure changes within the removable assay cartridge.
2. The system of claim 1 , wherein the plunger rod is coupled to the lead screw by a transverse arm.
3. The system of claim 2 , wherein the plunger rod is operable to engage a plunger tip of a removable assay cartridge.
4. The system of claim 1 , wherein the BLDC motor is configured to alter its motion to change the pressure within the removable assay cartridge based on detection of a change in the current.
5. The system of claim 4 , wherein altering the operation of the BLDC motor comprises raising the plunger rod to reduce pressure within the removable assay cartridge.
6. The system of claim 4 , wherein altering the operation of the BLDC motor comprises lowering the plunger rod to increase pressure within the removable assay cartridge.
7. The system of claim 4 , wherein altering the operation of the BLDC motor comprises decelerating the plunger rod to reduce a pressure rate within the removable assay cartridge.
8. The system of claim 4 , wherein altering the operation of the BLDC motor comprises accelerating the plunger rod to increase a pressure rate within the removable assay cartridge.
9. 1. A method of operating a syringe drive for a diagnostic assay system, comprising: a brushless DC (BLDC) motor, without any position or pressure sensors and without any encoder hardware, operable to rotate a back-drivable lead screw, a plunger rod coupled to and movable thereby, and receiving a command to power the BLDC motor; providing power to the BLDC motor to move the plunger rod to engage a plunger tip within a syringe passage of a removable assay cartridge; monitoring movement of the plunger rod within the syringe passage by monitoring at least one current associated with operation of the BLDC motor, the current varying in response to pressure changes; Detecting a current change of the BLDC motor; modifying operation of the BLDC motor to vary movement of the plunger rod within the removable assay cartridge based on the detected change in current in the BLDC motor; The method includes:
10. 10. The method of claim 9, wherein monitoring at least one current in the BLDC motor occurs during movement of the plunger rod.
11. The method of claim 10, wherein altering the operation of the BLDC motor comprises raising the plunger rod to reduce pressure within the removable assay cartridge.
12. The method of claim 10, wherein altering the operation of the BLDC motor comprises lowering the plunger rod to increase pressure within the removable assay cartridge.
13. The method of claim 10, wherein altering the operation of the BLDC motor comprises decelerating the plunger rod to reduce a rate of pressure change within the removable assay cartridge.
14. The method of claim 10, wherein altering the operation of the BLDC motor comprises accelerating the plunger rod to increase a rate of pressure change within the removable assay cartridge.
Citation Information
Patent Citations
Syringe Pump and Related Method
US20130281965A1
Door opening / closing device
WO2011132219A1
Universal docking bay and data door in a fluidic analysis system
WO2014039703A1
Sample-manipulating device
WO2015086445A1
